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ABSTRACT 
 
Dengue virus (DENV) is the most prevalent arbovirus globally, infecting an 
estimated 400 million people each year. DENV belongs to the Flaviviridae family of 
viruses, and is closely related to Zika virus (ZIKV), West Nile virus (WNV), and yellow 
fever virus (YFV). To date, there are no approved antivirals for the treatment of dengue, 
in part due to the poor understanding of DENV replication and interactions with its host 
cell.  We performed a genome-wide CRISPR-Cas9 knockout screen in human 
hepatoma Huh-7 cells to identify host dependency factors for DENV and reveal potential 
therapeutic targets. We found that two major protein complexes are necessary for 
DENV replication, the oligosaccharyltransferase (OST) complex and the endoplasmic 
reticulum membrane protein complex (EMC). 
We show that two mammalian OST complexes that incorporate either STT3A or 
STT3B, the catalytic subunits responsible for N-linked glycosylation, are necessary for 
DENV replication. However, the enzymatic activity of these subunits is not essential for 
replication. We found that expression of MAGT1 or its homolog TUSC3 is dependent on 
expression of STT3B, and that cells lacking MAGT1/TUSC3 are protected from DENV 
infection. Mutagenesis studies of MAGT1 revealed that a conserved CxxC motif shared 
among oxidoreductases is required for efficient DENV infection, suggesting that MAGT1 
acts as an oxidoreductase to support DENV infection. We also provide evidence that the 
STT3B/MAGT1 OST complex interacts with NS4B and may be important for its 
biogenesis and folding. 
We also show that the EMC, which contains ten subunits EMC1 through EMC10, 
is also necessary for DENV replication. The EMC has been proposed to function as a 
chaperone and insertase for transmembrane proteins. We found that cells lacking the 
EMC support significantly reduced levels of flavivirus NS4A and NS4B, both of which 
 xii 
are multi-pass transmembrane proteins that contain domains with marginal 
hydrophobicity. Importantly, we demonstrate an interaction between the EMC and NS4B, 
but not NS1 or NS2B, during viral replication. We show that deletion or mutagenesis of 
two marginally hydrophobic domains of NS4B render its expression no longer 
dependent on the EMC. Taken together, our data suggest that the EMC promotes the 
expression of NS4B via an interaction with marginally hydrophobic domains, a feature 
that may apply to other cellular EMC substrates as well. 
In a tangentially related project, we found that exogenous expression of a 
hypoglycosylated N207A mutant of DENV NS1 blocked DENV infection in a dominant-
negative fashion. Similarly, we found that expression of an N130A mutant of ZIKV NS1 
inhibited both DENV and ZIKV infection. Immunofluorescence microscopy revealed that 
these NS1 mutants exhibited a filamentous phenotype upon flavivirus infection, rather 
than the punctate distribution of wild-type NS1. We further designed NS1 mutants that 
were able to inhibit DENV, YFV, and ZIKV infection, and we speculate that they may 
also prevent infection by other flaviviruses. While the mechanism of inhibition is still 
unclear, these mutants may be useful tools to study the role of NS1 in flavivirus 
replication, and potentially in preventing flavivirus transmission. Our novel findings 
demonstrate cross-flavivirus dominant-negative inhibition of replication by NS1 mutants. 
In summary, these findings provide a deeper understanding of flavivirus biology 
and help elucidate the roles of these cellular complexes in viral replication. 
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CHAPTER I 
Introduction 
 
Dengue disease 
Dengue virus (DENV) is the etiologic agent of dengue fever, which can manifest 
with a spectrum of acute symptoms such as a fever, rash, joint pains, vomiting, with less 
than 5% of dengue infections resulting in severe illness called dengue hemorrhagic 
fever or dengue shock syndrome. Dengue virus is transmitted primarily by the Aedes 
aegypti mosquito, which is geographically restricted to subtropical regions of the world 
(1). Unfortunately, projections estimate that climate change will result in the expansion 
of the Aedes vector range, leading to the increased incidence of dengue and other 
arboviruses (2-4). There are four DENV serotypes that co-circulate in regions with 
endemic DENV(5). Genetically related flaviviruses, such as Zika virus (ZIKV), yellow 
fever virus (YFV), and West Nile virus (WNV) are also transmitted by mosquito, and 
often cause symptoms similar to dengue. Approximately 80% of DENV infections are 
asymptomatic, with an estimated 400 million people each year becoming infected by 
DENV, and approximately 100 million presenting with disease (6). To date, no approved 
antivirals exist for the treatment of dengue, due at least in part to the poor 
understanding of the DENV host-cell biology. 
 
Dengue virus  
Dengue virus (DENV) is an enveloped positive sense-single stranded RNA virus 
of the genus Flavivirus. Like all other viruses, DENV is an intracellular obligate parasite 
dependent on a host cell for reproduction. The DENV infection cycle is initiated by 
binding to the host cell surface, which has been shown to be cell type and serotype 
specific, with a number of putative receptors that mediate virus entry (7). The virion is 
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internalized via endocytosis, and a reduction in pH by the vacuolar-type H+-ATPase 
complex within the endosome triggers a conformational change in the viral structural 
protein E, inducing fusion of the viral envelope with the endosomal membrane (8). The 
viral capsid carrying the positive-sense genome delivers the genome to the cytosol 
where it is translated at the endoplasmic reticulum (ER).  
 All flaviviruses contain a similar genetic organization, having a single open 
reading frame that is translated as a polyprotein and cleaved into ten individual proteins 
(Figure 1.1). At the N-terminus of the polyprotein are the three structural proteins that 
comprise the virion, and toward the C-terminus are the seven non-structural (NS) 
proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5, which are necessary and 
sufficient to drive replication of the flavivirus genome (Figure 1.1) (9, 10). Cleavage of 
the polyprotein is mediated by various proteases, including the host signalase complex, 
the viral NS2B-NS3 protease, and a still unidentified protease that cleaves between NS1 
and NS2A (11, 12). Of the seven non-structural proteins, only the NS2B-NS3 
protease/helicase and NS5 RNA-dependent RNA polymerase and methyltransferase 
have known enzymatic functions (13-16). The other NS proteins lacking known 
enzymatic functions, NS1, NS2A, NS4A, and NS4B, have been proposed to carry out 
other pro-viral functions necessary for replication, such as immune evasion and 
remodeling of the ER membrane necessary for the establishment of the flavivirus 
replicase, also known as the replication organelle (RO) (9, 17, 18). 
Genome replication of virtually all positive-sense RNA viruses occurs on a host-
derived membrane, such as the ER, rather than freely in the cytoplasm (19). In general, 
RO morphology is virus-dependent and can be divided into two types. For instance, 
DENV induces vesicular invaginations of the ER membrane, while HCV infection leads 
to the formation of double membrane vesicles that protrude from the ER (20). In the 
case of DENV, the vesicular RO encompasses the viral genome and replicative 
intermediates such as double-stranded RNA (dsRNA) (Figure 1.2) (19-21). Additionally, 
some ER-resident cellular machinery is recruited to the RO and has been shown to be 
important for viral replication. 
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During infection, flaviviruses selectively repress host translation, strongly favoring 
viral translation (22). Not surprisingly, the cellular co-translational machinery including 
the Sec61 translocon, the oligosaccharyltransferase (OST) complex, and the 
endoplasmic reticulum membrane protein complex (EMC) are required for flavivirus 
replication (12, 23-26). Importantly, the OST localizes to the RO, though its function 
during flavivirus replication is still unclear (26). A review of these major protein 
complexes will be discussed later in this chapter. 
The localization of the non-enzymatic non-structural proteins to the RO suggests 
that they likely participate in genome replication, possibly through rearranging the ER 
membrane to generate ROs. However, their specific roles in this process are poorly 
understood. While multiple non-structural proteins antagonize innate immune pathways, 
these non-structural proteins also play more direct roles in supporting viral replication 
(18). The behavior and roles of NS1, NS4A, and NS4B in flavivirus replication are 
further discussed below. 
 
NS1 
Flavivirus NS1 is a 352 amino acid glycoprotein whose structure is highly 
conserved across flaviviruses, despite significant sequence variation. The 24 C-terminal 
amino acids from E protein serve as a signal sequence for the insertion of NS1 into the 
ER lumen, where NS1 is glycosylated by the oligosaccharyltransferase (OST) complex 
at positions N130 and N207 with high-mannose carbohydrates (27-29). The function of 
NS1 glycosylation has not been elucidated, though multiple studies have shown that 
NS1 glycosylation is essential for efficient genome replication. Hypoglycosylation of NS1 
by mutation to the N130 and N207 sequons have varying virus-specific effects, usually 
resulting in attenuation of viral replication (30-34). In addition, glycosylation at N207 has 
been reported to mediate oligomer stability and heat sensitivity (29, 32, 35). Viruses 
harboring mutations to both glycosylation sites were genetically unstable, further 
reinforcing the importance of glycosylation in replication (31, 33). 
The NS1 monomer harbors 12 cysteines that form 6 intramolecular disulfide 
bonds necessary for NS1 folding and viral propagation (36, 37). The short-lived 
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monomer rapidly homo-dimerizes in the ER lumen within 20 minutes of translation (38). 
The highly conserved structure of the NS1 dimer can be separated into three structural 
domains: a short β-roll (1-29), a wing domain (30-180), and the β-ladder (Figure 1.3) 
(181-352) (39). The β-roll consists of two intertwined β-hairpins that have been 
proposed to mediate NS1 dimerization, lipid interaction, and association with other NS 
proteins (Figure 1.3) (39-41). The β-ladder consists of 18 anti-parallel β-strands that 
resemble a ladder along the length of the dimer (39). A discontinuous connector sits 
against the β-roll, joining the wing domain with the β-roll, and forming a hydrophobic 
spike that has been proposed to mediate membrane interactions (39, 41, 42). The wing 
is further comprised of an α/β subdomain and a disordered wing tip that is necessary for 
its interaction with the DENV virion during viral assembly (40). 
While evidence suggests dimerization is necessary for its function, a single report 
has described a replication-competent Kunjin virus encoding a monomeric NS1 
harboring an L250P mutation (43). However, studies with other viruses have failed to 
recapitulate this effect, and attempts to destabilize the DENV NS1 dimer by 
mutagenesis have not been successful (32, 44, 45). The NS1 dimer is primarily 
localized to the RO, localizing with dsRNA and other non-structural proteins, suggesting 
a role for NS1 in genome replication (46). Despite considerable effort, studies have yet 
to yield significant advances in the understanding of NS1 function. Being an ER lumenal 
protein, NS1 is physically excluded from the interior of the RO, making it unlikely that 
NS1 interacts directly with the cytoplasmic-facing replication machinery. Instead, NS1 
associates with NS4A, NS4B, and host factors to assist in replication. Evidence of a 
biochemical interaction between NS1 and NS4A was first identified in Kunjin virus, and 
further reinforced using YFV, by using both genetic and biochemical techniques (17, 46, 
47). However, the same has not been conclusively shown for DENV. In addition, 
passage of WNV harboring inhibitory NS1 mutations led to adaptive mutations in NS4B, 
suggesting an interaction between the two proteins (41). Other evidence using mass-
spectrometry of NS1-interacting proteins during viral infection has further reinforced that 
NS1 and NS4B are likely associated during infection (28, 48, 49). It is possible that this 
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interaction between NS1 and NS4B induces conformational changes that drive RO 
formation, and regulate viral replication.  
NS1 may also recruit cellular pro-viral factors within the ER lumen to the RO to 
facilitate viral replication. Efforts to identify these NS1-interacting factors have revealed 
a number of proteins that may interact with NS1 during viral infection such as the OST, 
ribosomal machinery, vimentin, and the chaperonin-containing TCP-1 (CCT) complex 
(also known as the TRiC) (26, 28, 50, 51). While NS1 no doubt interacts with cellular 
machinery, the nature of its interactions and whether they are important for viral 
replication is still unclear. 
In addition to participating in genome replication at the flavivirus RO, NS1 plays a 
role in viral assembly through its interactions with E and M glycoproteins during infection 
(40). A fraction of NS1 is also secreted from the cell as a hexamer (35). Surprisingly, the 
process of NS1 secretion is dispensible for genome replication (40). Soluble hexameric 
NS1 enhances flavivirus infection when exogenously added to cell culture media (52). 
Levels of NS1 in patient blood correlate with disease severity, and secreted NS1 has 
been reported to enhance dengue pathogenesis through interactions with the 
complement system, and inducing vascular permeability (53-56). In addition, NS1 in 
host sera enhances flavivirus uptake into naïve mosquitos, also suggesting a role for 
NS1 in flavivirus transmission (57). In summary, NS1 clearly plays roles in replication, 
immunity, and disease, but its exact function in each of these processes has yet to be 
clarified. 
 
NS4A and NS4B 
Similar to NS1, NS4A and NS4B localize at the RO during infection, suggesting 
they participate in viral replication. NS4A is a 127 amino acid multi-pass transmembrane 
protein with a C-terminal 2kDa peptide, termed 2K, which functions as a signal 
sequence for NS4B. Cleavage between NS4A and 2k is mediated by the viral NS3 
protease, liberating NS4A and 2k-NS4B (58). The N-terminal amphipathic helix is 
important for NS4A oligomerization and its interaction with NS4B (59-63). NS4A also 
contains two transmembrane helices with a third ER lumenal helix between the two 
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transmembrane domains (64). Overexpression of NS4A alone is sufficient to induce 
membrane rearrangements (65). The combined evidence suggests that NS4A plays a 
critical role in RO assembly and possibly curvature of the RO. 
NS4B is a conserved 248 amino acid protein inserted into the ER lumen. An N-
terminal 2K peptide is required for proper insertion of NS4B into the ER membrane, and 
is cleaved by a host signalase from the mature NS4B (66). NS4B has five putative 
transmembrane domains, with multiple membrane-associated hydrophobic-rich patches 
throughout the protein (67). A biochemical study using NS4B fusion proteins and 
protease protection assays suggested that only three C-terminal helices span the 
membrane, while the N-terminal two putative transmembrane helices (pTM1 and pTM2) 
are membrane-associated or reside within the ER lumen (66). By contrast, NMR studies 
using recombinant NS4B have suggested that the N-terminal helices are embedded in 
the membrane (68, 69). Indeed, transmembrane prediction tools identify the domains as 
potential transmembrane helices, but with relatively low probability of being membrane-
inserted, an aspect that will be further discussed in Chapter III. Despite attempts to 
clarify NS4B topology, much of its biochemistry and folding have remained an enigma. 
Additionally, DENV-2 NS4B encodes four glycosylation sequons, but is only 
partially glycosylated during infection (70). Mutagenesis revealed that the two N-terminal 
sequons located between pTM1 and pTM2 are necessary for efficient replication (70). It 
is unlikely that NS4B glycosylation is required for proper folding, because only a minor 
fraction is glycosylated in infected cells. One group has also shown that recombinant 
NS4B is capable of forming oligomers, though oligomerization has not been definitively 
shown during infection (71). 
Early during infection, NS4B is localized to the perinuclear region of the cell, and 
later forms distinct foci along with the other NS proteins at the ROs, suggesting a role 
for NS4B in replication (17, 72). Interactions between NS4B, NS4A, and NS1 may affect 
NS4B folding, topology, and function (73). NS4B reportedly interacts with NS3, possibly 
playing a role in coordinating the helicase and protease activities of NS3 (71, 74). NS4B 
can also be found at the mitochondria, where it inhibits innate immune responses and 
interacts with ATP synthase machinery, which the authors speculate may be important 
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for biogenesis of the replication organelle (75). Unfortunately, further interactions 
between NS4B and host proteins during viral infection have not yet been deeply 
explored. 
NS4B was noted as a “mutational hotspot,” with a high frequency of adaptive 
mutations (73). A number of mutations across NS4B improve flavivirus replication in cell 
culture, and others enhance pathogenesis in vivo (76-80). Despite a wide variety of 
identified NS4B mutations that enhance replication, the mechanism by which NS4B 
modulates replication is still inconclusive.  
 
The oligosaccharyltransferase complex 
DENV, and other flaviviruses, are highly dependent on the ER for replication, 
since the ER membrane is co-opted to establish the RO (20). Not surprisingly, many ER 
resident proteins are essential for DENV replication. The two ER complexes that were 
subjected to extensive study in this work are the OST complex and the EMC. 
Protein glycosylation is an important cellular process that mediates protein 
folding, stability, trafficking, and localization (81). The OST complexes are responsible 
for asparagine-linked glycosylation, the transfer of oligosaccharides onto target proteins 
containing N-x-S/T sequons within the ER lumen (82). Vertebrates, insects, and plants 
express at least two OST isoforms that incorporate either of the paralogous catalytic 
subunits STT3A or STT3B (83). Both STT3A and STT3B harbor a conserved WWDYG 
catalytic motif that is required for enzymatic activity (84). Despite their functional 
redundancy, some cellular substrates are dependent on either STT3A or STT3B for 
efficient glycosylation, though the determinants that guide OST specificity have yet to be 
elucidated (82). Additionally, some peptides require both STT3A and STT3B for 
complete glycosylation, though STT3B has been shown to at least partially compensate 
in cells lacking STT3A (85). 
Data suggest that STT3A is responsible for co-translational glycosylation of 
target proteins, while STT3B functions post-translationally on sequons skipped by 
STT3A (85). This difference in functionality is due in part to the isoform-specific subunits 
that comprise the STT3A or STT3B complexes. The STT3A complex contains two 
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isoform-specific subunits, KCP2 and DC2 (86). DC2 and KCP2 mediate the interaction 
between the OST and the Sec61 translocon (87). By contrast, the STT3B complex 
associates with the thioredoxin homolog MAGT1, or its paralog TUSC3, which both 
harbor oxidoreductase activity via a conserved CxxC motif (88, 89). The CxxC active 
site forms mixed disulfides with target proteins in the ER, granting STT3B access to 
sequons for glycosylation (88). Structural studies of the TUSC3 soluble domain revealed 
a peptide-binding groove that may guide substrate recognition, though determinants of 
peptide binding have yet to be identified (89). 
Both of the OST complexes are additionally comprised of the shared OST 
subunits RPN1, RPN2, OST4, OST48, DAD1, and TMEM258 (90-94). The DC2 and 
KCP2 subunits mediate the interaction between the OST and the Sec61 translocon (87). 
RPN1 and RPN2 ribophorins link the OST with ribosomal machinery in the cytosol, 
assisting in co-translational glycosylation (95-97). OST4 and DAD1 may be necessary 
for OST complex stability, though their functions are still unclear (98, 99). While not all 
OST subunits have been well characterized, it has become clear that each subunit is 
necessary for efficient N-linked glycosylation. 
 
The endoplasmic reticulum membrane protein complex (EMC) 
The EMC was first identified in yeast, where genetic ablation led to accumulation 
of misfolded proteins and induction of the unfolded protein response (100). Initially, 
immunoprecipitation of the complex from yeast established six proteins, EMC1-6, as 
core EMC components (100). Further studies with mammalian cells revealed four 
additional potential EMC subunits, EMC7-10, with each EMC subunit 1-10 present in 
roughly stoichiometric ratios (101, 102). Primary studies identified the EMC as critical for 
protein folding and ER-associated degradation (ERAD) pathways, though its detailed 
function was entirely unclear. Studies into the function of the EMC have been hampered 
in part due to the poor homology between EMC subunits and proteins of known function. 
EMC1 is the largest subunit of the complex, 993 amino acids in length, with a 
single C-terminal transmembrane domain anchoring it to the ER membrane. EMC2 is a 
cytosolic putative tetratricopeptide repeat protein comprising three degenerate motifs 
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that have been shown to mediate protein-protein interactions. EMC3 is a multipass 
transmembrane protein with homology to the bacterial YidC or mitochondrial oxa1 
membrane protein insertases (103). EMC4 and EMC6 (TMEM93) are each small (<20 
kDa) multipass transmembrane proteins with negligible homology to proteins with 
known activities, and thus no putative function. EMC5 (MMGT1) is annotated as a 
magnesium transporter due to its weak homology with MMGT2 and partial localization 
to Golgi vesicles after overexpression (104). A single study showed that knockdown or 
overexpression of EMC5 modulates Mg2+ transport; however current data suggests that 
the EMC is necessary for expression of transmembrane proteins, likely those 
responsible for Mg2+ transport (104). Future studies will reveal whether EMC5 homology 
to other magnesium transporters may provide insight to its function in the EMC. 
The data to date support the hypothesis that the EMC functions as a 
transmembrane chaperone or insertase. Initial evidence supporting this model was that 
biosynthesis of various transmembrane proteins is dependent on the EMC, including 
acetylcholine receptors and rhodopsin in C. elegans and Drosophila respectively (105, 
106). Later studies showed that the EMC can function as an insertase, and is sufficient 
for membrane insertion of an in vitro translated tail-anchored single pass 
transmembrane protein (107). However, three studies have shown that expression of 
multipass transmembrane proteins was specifically impaired in cells depleted of the 
EMC, suggesting the EMC functions as more than a tail-anchored membrane protein 
insertase (102, 105, 106).  
Furthermore, experiments revealed that the EMC participates co-translationally in 
the biosynthesis of “folding-challenged multipass client proteins” (102). More specifically, 
these putative EMC clients contain transmembrane domains enriched in charged amino 
acids and depleted of classic hydrophobic residues usually found in transmembrane 
helices (102). The authors speculated that the EMC engages these difficult-to-fold 
transmembrane proteins, delaying their degradation by ERAD, and recruits chaperones 
to assist in folding (102). In support of this model, another group has shown that the 
EMC binds HSP90, though the importance of this interaction for EMC function has not 
been defined (108). Together, these data suggest a specific role for the EMC in the 
 10 
biogenesis and stability of multipass transmembrane proteins, though some studies 
have also suggested the EMC plays roles in other cellular processes. 
The EMC has also been postulated to function as an ER-mitochondrial tether 
responsible for lipid transfer. However, this phenotype was only reproducible in the 
background of yeast harboring multiple EMC knockouts, and ablation of a single EMC 
subunit did not significantly affect lipid transfer (109). These data are also contradictory 
to others, where knockout of a single EMC subunit was sufficient to deplete other EMC 
proteins. One explanation for this contradiction is that depletion of multiple EMC 
subunits exacerbates the loss of specific transmembrane proteins necessary for ER-
mitochondrial tethering and/or lipid transfer.  
Other groups have also posited a role for EMC6 in autophagy, since knockdown 
of EMC6 marginally reduced autophagy compared to control cells when induced by 
chloroquine (110, 111). These effects may not be EMC6 specific, as the authors did not 
address whether depletion of other EMC subunits also results in a similar phenotype. 
Whether the EMC plays a direct role in autophagy has yet to be clarified. 
The EMC is important for the propagation of multiple viruses. For polyomavirus 
SV40, the EMC is necessary for ER membrane penetration and entry, further reinforcing 
a role for the EMC as a chaperone (112). The EMC has also been identified as a host 
dependency factor for multiple flaviviruses including WNV, YFV, and ZIKV (12, 25, 26, 
113). For DENV, the EMC inhibits at a stage early in the viral life cycle (25). The EMC 
also associates with the OST, further supporting a potential role for the EMC at the RO 
(25).  
Many questions still remain regarding the EMC and its function. What are 
determinants that drive EMC dependence of multipass transmembrane proteins? Does 
the EMC recruit co-chaperones to assist in substrate folding? What is the function of 
each of the EMC subunits? What role does the EMC play during flavivirus infection? 
 
CRISPR-Cas9 screens 
Significant effort has been applied to identify viral host dependency factors, in an 
effort to develop antiviral therapeutics that target the host rather than viral proteins. High 
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throughput genome-wide screens have been valuable tools for identifying these host 
dependency factors. Sessions et al. in 2009 were the first to publish a genome-wide 
screen using RNA interference to identify DENV host dependency factors (114). 
However, methods employing interfering RNAs have significant weaknesses, including 
off-target effects, depletion limits, and low reproducibility (115-117). Recently, tools 
based on the clustered regularly interspaced short palindromic repeat (CRISPR) Cas9 
system have expanded our ability to efficiently and accurately modify genomes.  
The CRISPR-Cas9 system involves a Cas9 endonuclease that is guided by a 
single guide RNA (RNA) molecule, which is composed of a 20 nucleotide targeting RNA 
(crRNA) fused to a structured RNA that interacts with the Cas9 protein (tracrRNA) (118). 
Homology between a segment of the genome and the crRNA directs the Cas9 nuclease 
toward a specific site in the genome, inducing a double-stranded break at a site termed 
the protospacer adjacent motif (PAM), which is between 3-6 nucleotides from the 
sgRNA binding site (119). The double-stranded break is repaired either by homologous 
recombination, or by non-homologous end-joining, which most often results in frameshift 
mutations, effectively generating a genetic knockout (120). Feng Zhang’s group at MIT 
developed a lentiviral vector library encoding sgRNAs targeting the entire human 
genome paired with a Cas9 and a puromycin selection marker for the generation of 
pools of stable knockout human cells (121, 122). 
We used this tool to identify host dependency factors necessary for DENV 
propagation, which launched three intriguing projects that comprise this dissertation.  
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Figure 1.1. The DENV polyprotein. Adapted from (123). DENV is translated as a 
polyprotein, which is processed at the ER into ten individual proteins. At the N-terminus 
are the three structural proteins that comprise the DENV virion, C, prM and E. Next are 
the seven non-structural proteins that are necessary and sufficient for genome 
replication. NS1 is a soluble ER lumenal protein, NS3 and NS5 are cytosolic proteins, 
and NS2A, NS2B, NS4A, and NS4B are multi-pass ER transmembrane proteins. 
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Figure 1.2. The flavivirus replication organelle. Adapted from (20, 124). Dengue 
infection rearranges the ER membrane into two distinct types: convoluted membranes 
and vesicular replication organelles (RO) where genome replication occurs. The RO is 
an invagination of the ER membrane containing each of the non-structural proteins, the 
double-stranded RNA replicative intermediate, and host-factors (HF). 
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Figure 1.3. Flavivirus NS1. Adapted from (39). In A, the crystal structure of the West 
Nile virus NS1 dimer is shown. One monomer is colored in gray and the other color 
coded to indicate the three domains of NS1. The three glycosylated asparagines of 
West Nile virus NS1 are each labeled. In B, a surface plot of the same NS1 dimer 
rotated and embedded on the ER membrane surface. The NS1 β-roll mediates its 
interaction with NS4A, NS4B, and the ER membrane to support flavivirus replication. 
The wing domain of NS1 is important for its interaction with structural proteins and virion 
assembly. 
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CHAPTER II 
Identification and characterization of MAGT1 as a DENV host-dependency factor 
 This chapter consists of material from a research article in mBio, “Dengue Virus 
Hijacks a Noncanonical Oxidoreductase Function of a Cellular 
Oligosaccharyltransferase Complex”, written by David L. Lin, Natalia A. Cherepanova, 
Leonia Bozzacco, Margaret R. MacDonald, Reid Gilmore, and Andrew W. Tai (24). 
 Dr. Natalia A. Cherepanova performed pulse chase experiments demonstrating 
that NS1 is unchanged in OST knockout cells. Dr. Leonia Bozzacco performed infection 
experiments demonstrating that ZIKV is dependent on the OST. 
 
A whole genome CRISPR screen reveals that DENV is dependent on both cellular 
oligosaccharyltransferase complexes. 
We employed a CRISPR-Cas9 pooled screening approach to identify host 
proteins necessary for DENV-mediated cell death in Huh7.5.1 human hepatoma cells 
(Figure 2.1A). Among the top-ranked hits from the screen were multiple subunits of the 
host oligosaccharyltransferase (OST) complexes, including the two catalytic subunits 
STT3A and STT3B. Single-guide RNAs (sgRNAs) targeting genes encoding the two 
unique subunits of the STT3A and STT3B complexes, DC2 and MAGT1 respectively, 
were also significantly enriched in the screen (Figure 2.1B and C). In addition, two 
shared OST subunits, RPN2 and OST4, were significant hits (Figures 2.1B and C). 
Alternatively, the screen revealed at least two other major ER resident complexes as 
DENV host factors, the EMC and the SSR (Figure 2.2). To validate three of the hits from 
the screen, we generated STT3A, STT3B and MAGT1 knockout Huh7.5.1 cells through 
stable transduction of the pLENTICRISPRv2 construct encoding both the S. pyogenes 
Cas9 protein and an sgRNA. The knockouts were confirmed by Western blot. 
Importantly, in STT3B knockout cells, MAGT1 protein was also depleted (Figure 2.3A), 
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as its stability requires interaction with STT3B (88). We then infected these cells with a 
luciferase reporter dengue virus (luc-DENV), where luciferase activity directly correlates 
with viral propagation. Three days post-infection, we assessed luciferase activity and 
saw a significant and marked decrease in luciferase activity in STT3A, STT3B, and 
MAGT1 knockout cells compared to control cells transduced with a control GFP-
targeting sgRNA, demonstrating that protection from DENV-mediated cell death in these 
knockout cells is mediated by inhibition of DENV infection rather than by a block of cell 
death signaling pathways (Figure 2.3A). The viability and growth of STT3A, STT3B, or 
MAGT1 knockout cells was similar to control cells (Figure 2.3E). These data validate the 
results from the screen and show that STT3A, STT3B, and MAGT1 are all required for 
efficient DENV propagation. 
 
The catalytic oligosaccharyltransferase activity of the OST complexes is not 
required for DENV replication. 
In order to confirm the specificity of our knockout cell lines, sgRNA-resistant 
STT3A and STT3B were then introduced by lentiviral transduction into the 
corresponding knockout cell lines to rescue STT3A (Figure 2.3B) or STT3B (Figure 
2.3C) expression. Importantly, we found that exogenous expression of STT3B in STT3B 
knockout cells led to restoration of endogenous MAGT1 expression (Figure 2.3C). 
Exogenous expression of STT3A or STT3B rescued luc-DENV infection in STT3A-
knockout or STT3B-knockout cells, respectively (Figs. 2.3B and C). These data confirm 
that STT3A and STT3B are specifically required for efficient DENV propagation. 
Both STT3A and STT3B are oligosaccharyltransferases necessary for the 
transfer of glycans to asparagines on target substrates (85). Mutation of a conserved 
WWDYG motif to WAAYG inactivates oligosaccharyltransferase activity (84). STT3A or 
STT3B knockout cells expressing catalytically dead STT3A (STT3A-dead) or STT3B 
(STT3B-dead) were able to support similar levels of DENV infection as their wild-type 
counterparts, demonstrating that the catalytic activity of STT3A or STT3B is not required 
for DENV propagation (Figs. 2.3B and C). 
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We also confirmed that these constructs were indeed catalytically inactive by 
transfecting the rescued cells with plasmids to express either prosaposin (pSAP) or 
SHBG, specific N-glycosylation substrates of STT3A and STT3B respectively. By 
Western blot, a majority of pSAP remained hypoglycosylated, as evidenced by a more 
rapidly migrating band on SDS-PAGE from both STT3A knockout cells and STT3A-dead 
expressing cells (Figure 2.3B). Similarly, a fraction of SHBG appeared as a more rapidly 
migrating hypoglycosylated protein in both STT3B knockout cells and STT3B-dead 
expressing cells (Figure 2.3C). These results demonstrate that glycosylation of STT3A 
and STT3B specific endogenous substrates remains impaired in STT3A-dead and 
STT3B-dead expressing cells. 
We also transfected a luciferase-DENV replicon into knockout cells to assess 
whether the specific step of viral replication requires STT3A or STT3B. We found  
significant decreases in luciferase activity in STT3A and STT3B knockout cells 
compared to wild-type control at 48 hours and 72 hours post-transfection (Figure 2.3D). 
These data confirm that both of the OST complexes are required for DENV replication, 
consistent with previous data(26). The viability of OST knockout cells was unchanged 
compared to controls (Figure 2.3E).  
Together, these data suggest that STT3B stabilizes MAGT1 and that the 
canonical oligosaccharyltransferase activity of STT3B-containing OST complexes is not 
required for DENV propagation. These results support a model where STT3B is required 
to stabilize MAGT1, which in turn has its own specific function to support DENV 
replication. Therefore, we explored whether the catalytic activity of MAGT1 is required 
for DENV replication.  
 
The OSTs are required to support efficient infection by Zika virus but not other 
flaviviruses 
 We next asked whether other arboviruses also depend on the same OST 
complexes, and used flow cytometry to determine whether infection was impaired in 
STT3A or STT3B knockout cells. We infected cells with DENV-2, Zika virus (ZIKV), 
West Nile virus (WNV), yellow fever virus (YFV), Sindbis virus (SINV), Venezuelan 
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Equine Encephalitis virus (VEEV), or Chikungunya virus (CHIKV) and compared the 
percentage of infected cells in OST knockout cells compared to control. Consistent with 
our other results, we found that DENV-2 infection was dramatically reduced in OST 
knockout cells compared to control (Figure 2.4). We also found that ZIKV infection was 
moderately, but significantly, reduced in STT3A and STT3B knockout cells indicating 
that the OSTs may also play a role during ZIKV infection (Figure 2.4). However, we did 
not find a significant decrease in the propagation of the other viruses tested. 
 
The catalytic activities of TUSC3 or MAGT1 are necessary to support DENV 
propagation 
Both MAGT1 and its paralog TUSC3 are thioredoxin homologs that harbor 
oxidoreductase activity through a conserved catalytic CxxC motif, and interact with 
STT3B but not STT3A (88). TUSC3 contains a peptide-binding pocket that may interact 
with proteins in a sequence specific manner (89). Cells lacking both MAGT1 and 
TUSC3 are unable to fully glycosylate STT3B specific substrates (88). These data 
support a model where MAGT1 or TUSC3 serve to form a mixed disulfide with a protein 
substrate, granting STT3B access to glycosylation sites that may otherwise be 
inaccessible. 
In some cell types, TUSC3 expression is upregulated in the absence of MAGT1 
(88). Importantly, although TUSC3 has been shown to be expressed in HEK293T cells 
(88), we found that TUSC3 is not expressed in wild-type or MAGT1 knockout Huh-7.5.1 
cells by immunoblotting (Figure 2.5A) or by RT-PCR (not shown). Therefore, we asked 
whether TUSC3 is capable of functionally replacing MAGT1 in the context of DENV 
infection. We found that MAGT1 knockout Huh 7.5.1 cells transduced with a TUSC3-
encoding lentiviral vector were able to support significantly increased DENV propagation 
compared to cells expressing neither MAGT1 nor TUSC3 (Figure 2.5A). These data 
demonstrate that the expression of either MAGT1 or TUSC3 is required for DENV 
propagation, and that these two proteins are functionally redundant in the context of 
DENV propagation. 
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We next asked whether the enzymatic activity of MAGT1 or TUSC3 is required 
for DENV propagation. Expression of catalytically inactive AxxA mutants of MAGT1 or 
TUSC3 failed to rescue DENV propagation in MAGT1 knockout Huh7.5.1 cells (Figures 
2.5A and B), indicating that the oxidoreductase activity of MAGT1 or TUSC3 is required 
for DENV replication. 
We also investigated whether MAGT1 knockout cells expressing single-cysteine 
active site MAGT1 mutants (CxxA and AxxC) are able to support DENV replication. 
Some single-cysteine mutants of ER resident oxidoreductases, such as protein disulfide 
isomerase (PDI), have been shown to retain oxidoreductase activity (125, 126), and 
single-cysteine MAGT1 mutants can form mixed disulfides with target proteins, 
demonstrating that they are reactive in cells (88). Interestingly, MAGT1 knockout cells 
expressing a single cysteine MAGT1 mutant were able to support increased levels of 
DENV replication compared to knockout cells, albeit at levels lower than with wild-type 
MAGT1 rescue (Figure 2.5B). This indicates that single cysteine MAGT1 mutants retain 
significant catalytic activity to support DENV infection. Together, these data 
demonstrate that the oxidoreductase activity of MAGT1 is required for DENV 
propagation, and that cells expressing single-cysteine MAGT1 are still able to support 
DENV replication. 
 
MAGT1 partially localizes to DENV replication compartments 
We next performed immunofluorescence microscopy on cells expressing an HA-
tagged MAGT1 construct (MAGT1-HA) to visualize the localization of MAGT1 during 
DENV infection. In uninfected Huh-7 cells, both wild-type MAGT1 and MAGT1 mutants 
were distributed in an intracellular reticular pattern consistent with ER localization 
(Figure 2.5C). This supports the evidence that MAGT1 is an ER-localized component of 
the OST complex, rather than the proposal that MAGT1 contributes to magnesium 
import at the plasma membrane (88, 127). We also found that the distribution of the 
mutant MAGT1-AxxA was similar to that of wild-type MAGT1, demonstrating that the 
inability of cells expressing MAGT1-AxxA to support DENV replication is not due to 
defects in subcellular localization. DENV infection was associated with partial 
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colocalization of MAGT1 with viral NS1 protein (Figure 2.5C). Additionally, co-
immunopreciptation assays demonstrated MAGT1-AxxA interaction with STT3B, 
indicating that MAGT1-AxxA’s inability to support DENV replication is not due to a 
defect in association with the OST complex (Figure 2.5D). These data are consistent 
with previous data showing that the OST localized to sites of DENV induced vesicle 
packets and replication compartments(26). 
 
NS1 is not detectably different in STT3A, STT3B, and MAGT1 knockout cells 
We hypothesize that MAGT1 functions as an oxidoreductase, potentially affecting 
the folding of a DENV non-structural protein. We asked which DENV proteins could be 
candidate substrates for MAGT1 oxidoreductase activity. All four DENV serotypes are 
impaired in their ability to propagate in STT3B knockout cells (26), which based on our 
data must also lack MAGT1 expression. Therefore, we hypothesized that a viral target 
of MAGT1 oxidoreductase activity should have cysteines exposed to the ER lumen that 
are conserved across all four serotypes.  
Four of the seven nonstructural proteins have cysteine residues predicted to be 
exposed to the ER lumen: NS1, NS2A, NS4A, and NS4B. Of these proteins, only NS1 
and NS4B have cysteines that are conserved across all four DENV serotypes. The 
DENV protein NS1 forms a dimer in the ER, is secreted as a soluble hexamer, and 
contains twelve cysteines, six disulfide bonds, and two N-glycosylation sites (128). The 
DENV protein NS4B contains three cysteines and two N-glycosylation sites (70). 
We first investigated whether we could detect any changes in NS1 properties by 
immunoblotting of NS1 expressed in knockout and wild-type cells. We were unable to 
detect any changes in NS1 dimerization or glycosylation in STT3A or STT3B knockout 
cells (Figure 2.6A). We also found that the pattern of NS1 glycosylation was unchanged 
after performing pulse-chase experiments in STT3A, STT3B, or MAGT1/TUSC3 
knockout cells (Figure 2.6B). We were also unable to detect any interaction between 
NS1 and STT3B or MAGT1 by co-immunoprecipitation (not shown). In summary, these 
data suggest that glycosylation of NS1 is unaffected by the loss of STT3A, STT3B, or 
MAGT1, and that NS1 is not a target of MAGT1 oxidoreductase activity. 
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NS4B synthesis is altered in STT3B knockout cells 
We next sought to find differences in NS4B exogenously expressed in OST 
subunit knockout cells by generating tagged constructs expressing C-terminally tagged 
DENV 2k-NS4B-HA (pNS4B-HA) or 2k-NS4B-V5 (pNS4B-V5). NS4B has been 
proposed to be glycosylated at two residues, N58 and N62 (70). In 293T cells, we found 
that the pattern of NS4B-HA glycosylation was altered in cells expressing STT3B-dead 
compared to wild-type STT3B, with the apparent loss of accumulation of higher 
molecular weight HA-reactive bands (Figure 2.7A). Additionally, following transient 
expression of NS4B in Huh7.5.1 cells, we found three specific PNGase F sensitive 
bands that migrated at a higher molecular weight than unglycosylated NS4B, confirming 
that NS4B can be partially glycosylated under our experimental conditions (Figure 2.7B). 
Together this data shows that NS4B glycosylation is primarily mediated by STT3B. 
Although glycosylation of NS4B is not necessary for viral replication, as catalytically 
inactive STT3B rescues DENV replication in STT3B knockout cells, this finding 
suggests that NS4B physically interacts with the STT3B OST complex in the ER lumen. 
We noticed a consistent reduction in NS4B protein levels in STT3B and MAGT1 
knockout cells, and hypothesized that NS4B protein folding may be affected by the loss 
of STT3B or MAGT1. To measure the steady state levels of NS4B in STT3B knockout 
cells, we co-transfected a plasmid expressing either NS1 or GFP to control for 
transfection efficiency and quantitated chemiluminescent band intensities to measure 
relative levels of NS4B synthesis in STT3B knockout cells. We found a consistent and 
statistically significant (p<0.0001) 20-25% decrease in NS4B band intensity in STT3B 
knockout cells compared to wild-type controls relative to transfection control (Figure 
2.7C). Despite this difference in NS4B steady-state levels, we did not find a difference in 
the half-life of NS4B in STT3B knockout cells compared to WT (Figure 2.7D), 
suggesting that the rate of synthesis, and not degradation, of NS4B is altered in STT3B 
knockout cells.  
Together, these data show that NS4B is an STT3B substrate that requires 
MAGT1 to be efficiently glycosylated. Furthermore, NS4B synthesis appears to be 
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reduced by the loss of STT3B/MAGT1. Taken together, although NS4B glycosylation is 
not necessary for DENV infection, these findings suggest that NS4B physically interacts 
with both STT3B and MAGT1. Furthermore, they suggest that one mechanism by which 
MAGT1 facilitates DENV propagation may be through promoting efficient synthesis of 
NS4B.  
 
Close proximity of MAGT1 to NS4B and NS1 during DENV infection 
Although our data so far suggested a possible interaction between 
STT3B/MAGT1 and NS4B, using conventional immunoprecipitation methods, we were 
unable to demonstrate a stable interaction between MAGT1 and NS4B (not shown). 
Therefore, we used the engineered peroxidase APEX2 to label proteins in close 
proximity to MAGT1 during DENV infection. APEX2 catalyzes the biotinylation of 
proteins within a 5-10nm radius in the presence of biotin-phenol and hydrogen 
peroxide(129). We generated a construct in which APEX2 was inserted between the 
signal sequence and MAGT1, placing APEX2 in the ER lumen near the MAGT1 active 
site. We stably transduced MAGT1 knockout cells to express the APEX2-MAGT1 fusion 
protein, and induced APEX2-mediated biotinylation in DENV infected cells. After lysis of 
the cells, we performed affinity purification of biotinylated proteins using streptavidin 
beads followed by SDS-PAGE and immunoblotting. 
We found that both NS1 and NS4B were specifically biotinylated by APEX2-
MAGT1 in DENV infected cells (Figure 2.8). To assess the specificity of APEX2 labeling, 
we probed for biotinylation of STT3A, which also associates with sites of DENV 
replication but does not interact with MAGT1 (26, 88), and found that STT3A is not 
biotinylated by APEX2-MAGT1 under these conditions (Figure 2.8). Similarly, the 
integral ER membrane protein VAPA is not biotinylated by APEX2-MAGT1. On the other 
hand, EMC3, another ER protein necessary for flavivirus propagation that was a hit in 
our screen and interacts with the OST complex (25), was biotinylated. These data are 
consistent with the model that MAGT1 likely resides at sites of DENV replication and 
either associates with or is in close physical proximity to DENV non-structural proteins. 
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The redox status of NS4B is unchanged in the absence of MAGT1 
We hypothesized that the NS4B cysteine redox state is modulated by MAGT1. 
To test this, we used Western blots to examine changes in NS4B migration on SDS-
PAGE after treating cell lysates with maleimide-PEG (mPEG), which covalently bonds to 
free reduced cysteine residues. The mPEG reagent has an average molecular weight of 
5 kDa, resulting in a shift in the apparent molecular weight of modified proteins 
visualized by Western blot. DENV NS4B has three conserved cysteines that may 
participate in disulfide bonds. As a negative control, we lysed cells in the presence of N-
ethylmaleimide (NEM), which covalently blocks all reduced cysteines, rendering them 
mPEG-nonreactive (Figure 2.9, lanes 1 and 2). As a positive control, we treated lysates 
with Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), which reduces all cysteines, 
allowing subsequent mPEG modification of all cysteines (Figure 2.9, lane 5). 
mPEG modified NS4B, when expressed in isolation, migrates the same in both 
wild-type and STT3B knockout cells, indicating that MAGT1 does not affect the cysteine 
redox state of NS4B (Figure 2.9, lanes 3 and 4). Additionally, a fraction of mPEG-
modified NS4B (lanes 3 and 4) runs at the same apparent molecular weight as fully 
reduced TCEP-treated NS4B treated with mPEG (lane 5), indicating that at steady state, 
a fraction of NS4B molecules contains fully-reduced cysteines. However, another 
fraction of NS4B is modified by fewer mPEG molecules (lanes 3 and 4), demonstrating 
that some NS4B molecules may contain oxidized cysteines in the form of intra- or 
intermolecular disulfide bonds.  
While our results indicate that MAGT1 does not modulate NS4B cysteine redox 
state when expressed in isolation, they do not rule out the possibility that MAGT1 
modulates NS4B cysteine redox status transiently and/or in the context of authentic viral 
infection. Further experiments will have to be carried out to determine whether NS4B 
disulfide bonds exist during infection.  
 
Discussion 
Our results demonstrate the high reproducibility of whole genome CRISPR 
screens compared to the low overlap among hits from siRNA-based screens for host 
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cofactors of viral infection. We compared the top hits from our CRISPR screen to those 
recently published and found that 15 of the top 25 hits from our screen were in the top 
1% of the other’s (Table 2.1)(26). By contrast, three independent siRNA screens for 
host dependency factors of DENV infection performed by the same group identified over 
150 high confidence hits; however, only 14% of hits from one independent siRNA library 
overlapped with hits from another siRNA library, even when performed by the same 
investigators using the same infection conditions (25). This is consistent with meta-
analyses demonstrating the low reproducibility of siRNA screens for viral host factors 
(130).  
While there is a high degree of overlap between CRISPR screens for DENV, the 
number of significant hits is relatively low compared to those obtained from RNAi 
screens. For example, the pooled results of the three siRNA screens for DENV yielded 
hundreds of hits whereas our CRISPR screen yielded fewer than 50 significant hits. This 
may be due in part to some DENV host factors also being necessary for cellular survival 
or growth. Additionally, using cell survival from lethal viral challenge as a readout is 
highly stringent and will increase the false-negative rate, as only partial suppression of 
DENV infection may not be sufficient to protect cells from death. Thus, experimental 
readouts that can capture intermediate phenotypes are likely to reveal additional host 
dependency factors for DENV infection.  
The events at the endoplasmic reticulum that direct the formation of a functional 
dengue virus replication organelle remain incompletely understood. In this study, a 
whole-genome CRISPR screen reveals a non-canonical function of the OST complex 
that serves to support DENV infection. STT3B, the subunit of the OST complex that 
provides oligosaccharyltransferase activity, is required to stabilize MAGT1 to support 
DENV replication. We show that MAGT1, or its homolog TUSC3, provides a catalytic 
oxidoreductase activity necessary for DENV to replicate.  
On the other hand, we find that the N-glycosylation activity of STT3A or STT3B is 
dispensable for DENV propagation, in agreement with previous findings by Marceau et 
al. (26). Based on this observation, these authors suggested that the OST complexes 
serve as structural scaffolds for DENV to replicate. However, it is unclear why both 
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STT3A- and STT3B-containing OST complexes would be required to serve a scaffolding 
function for DENV replication. Our data show that STT3B-containing complexes serve 
more than a structural scaffolding function to support DENV replication, and in fact 
contribute a direct catalytic activity for DENV replication: namely, the oxidoreductase 
activity of MAGT1. We propose that the dependency of DENV replication on STT3B 
without requiring its oligosaccharyltransferase activity is explained by the loss of MAGT1 
expression in the absence of STT3B.  
Analogous to the dependence of MAGT1 on STT3B for stable expression, some 
subunits of the STT3A complex require STT3A for stable expression (86). We propose 
that there may be a specific function granted by the STT3A complex subunits 
DC2/OSTC or KCP2 that is necessary for DENV replication. In support of this 
hypothesis, DC2 was a hit in both CRISPR screens(26). However, the precise cellular 
function of DC2 is unknown. 
We have shown that the CxxC catalytic motif of MAGT1 or TUSC3 is required for 
DENV propagation, and that TUSC3 can functionally replace MAGT1 in the context of 
DENV infection. Some cell types, including HEK293 cells, express both TUSC3 and 
MAGT1, while others, including hepatocytes and Huh7.5.1 hepatoma cells, express only 
MAGT1 (127). Importantly, TUSC3 expression is upregulated in HEK293 cells when 
MAGT1 is knocked out (83). Thus, essential but functionally redundant functions of 
MAGT1 and TUSC3 in DENV replication will not be revealed in cell types capable of 
expressing both proteins.  
We carried out several experiments directed at the hypothesis that viral NS1 
and/or NS4B is a substrate of MAGT1, as these viral proteins harbor multiple cysteines 
conserved across all DENV serotypes that are also predicted to be accessible to 
MAGT1. We were unable to find any differences in NS1 dimerization or glycosylation in 
MAGT1 knockout cells compared to wild-type, suggesting that NS1 is correctly folded 
and processed in the absence of MAGT1. In addition, we probed the disulfide status of 
NS4B expressed in isolation, and found no apparent differences in NS4B cysteine 
accessibility to mPEG modification in the absence or presence of MAGT1 activity. 
Typically, both cysteines in the CxxC active site motif of an oxidoreductase are involved 
 26 
in catalyzing disulfide bond formation in a target protein. Surprisingly, cells expressing 
CxxA or AxxC active site mutants of MAGT1 can support DENV propagation. Single-
cysteine active site mutants of protein disulfide isomerase (PDI) have been shown to 
retain partial reductase activity in vitro, and are still able to shuffle disulfide bonds and 
mediate native protein folding (125, 126). Previous studies have shown that a single-
cysteine MAGT1 mutant exhibits partial catalytic activity when assessing glycosylation 
of an STT3B substrate (88). As depicted in Figure 2.10, a single-cysteine reductase can 
act as a disulfide isomerase by attacking a non-native disulfide bond on a target protein, 
generating a mixed disulfide between the reductase (here MAGT1) and its target. An 
alternate cysteine from the target protein then resolves the mixed disulfide, forming the 
native disulfide bond and releasing the target protein from MAGT1. Single-cysteine 
MAGT1 could therefore serve as a disulfide isomerase in the context of DENV infection. 
Alternatively, single-cysteine MAGT1 could function in tandem with another ER-resident 
oxidoreductase to resolve the mixed disulfide, and generate a correctly folded target 
substrate. However, this model is not easily reconciled with the observation that either 
single-cysteine or wild-type MAGT1 is capable of supporting DENV replication, because 
the majority of wild-type MAGT1 appears to be oxidized in cells, without reduced 
cysteines to attack disulfide bonds(88). One possibility is that the minor fraction of 
reduced MAGT1 or TUSC3 is sufficient to support DENV replication.  
If MAGT1 does not directly catalyze disulfide bond rearrangement in a DENV 
protein such as NS4B, another possibility is that MAGT1, though its oxidoreductase 
activity, recruits a DENV protein to another cellular protein or complex. For example, the 
OST complex has recently been identified to associate with proteins in the ER 
membrane complex (EMC), which has been reported to act as a chaperone for 
multipass transmembrane proteins, of which NS4B is an example (105, 112). In this 
model, MAGT1, through its oxidoreductase activity, might transiently interact with NS4B, 
recruiting it to the EMC as an NS4B chaperone. Although we were unable to 
demonstrate a stable interaction between MAGT1 and DENV non-structural proteins by 
coimmunoprecipitation, likely due to the transient association between oxidoreductases 
and their target substrates(131), APEX2-MAGT1 induced biotinylation of both NS4B and 
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NS1 in DENV infected cells, indicating that MAGT1 interacts with, or is at least in close 
proximity to, components of the DENV replication organelle in the ER.  
Consistent with the possibility that MAGT1 might help to recruit dengue 
nonstructural proteins to the EMC complex, the rate of NS4B synthesis appears to be 
reduced in cells lacking MAGT1 and STT3B. While we see only relatively modest 
reductions in NS4B expression in cells lacking STT3B and MAGT1, one caveat is that 
NS4B is expressed in isolation in our system. It is possible that loss of MAGT1 may 
have more detrimental effects on NS4B expression (or the expression of other DENV 
proteins) in the context of authentic DENV infection. However, the strong inhibition of 
DENV infection in OST knockout cells prevents accurate assessment of protein 
expression.  
We also found that ZIKV infection is significantly reduced in STT3A or STT3B 
knockout cells, suggesting that ZIKV may also require the OST complex for efficient 
infection or replication. However, the other flaviviruses tested did not appear to be 
dependent on OST complex function, despite the common dependence of most 
flaviviruses on the host cell ER for replication organelle formation. Interestingly, the 
NS4B cysteines are not conserved among flaviviruses despite being conserved across 
all DENV serotypes. 
In conclusion, our data demonstrate that the STT3B-containing OST complex 
serves a catalytic and non-canonical function during DENV replication, and not merely a 
scaffolding function. We hypothesize that this non-canonical oxidoreductase activity of 
MAGT1 acts on a DENV non-structural protein, such as NS4B, to mediate efficient 
synthesis, folding, and/or recruitment of non-structural proteins to specific sites in the 
ER. Our results improve our understanding the cell biology of DENV infection, and also 
may potentially guide the development of DENV antivirals that target MAGT1. 
 
Materials and Methods 
Pooled CRISPR screen 
The Human GeCKOv2 plasmid library was a gift from Feng Zhang, acquired from 
AddGene. VSV-G pseudotyped GeCKOv2 lentiviruses were generated at the University 
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of Michigan vector core. In brief, 16 million Huh-7 cells were transduced with the 
GeCKOv2 A or B lentiviral half-library at an MOI = 0.3 in 10 cm dishes. Cells were 
selected for 6 d post-transduction with 2 µg/mL puromycin, then infected with DENV-2 
16681 at an MOI = 0.1 for 2 weeks. Genomic DNA from surviving cells was harvested 
using a Quick-gDNA Midi kit (Zymo Research, Irvine, CA). The integrated sgRNAs were 
amplified using PCR, and Illumina adapters and barcodes were subsequently added by 
PCR as previously described (121). Sequencing was performed at the University of 
Michigan sequencing core on a MiSeq (Illumina, San Diego, CA), and data was 
analyzed using MaGeCK (132). 
 
Plasmids and lentiviral transduction 
Individual sgRNAs targeting STT3A, STT3B, and MAGT1 were generated in 
pLENTICRISPRv2 as previously described using the crRNA sequences listed in Table 
2.2. The lentiCRISPR - EGFP sgRNA 1 was a gift from Feng Zhang (Addgene plasmid # 
51760). 
The cDNA clone for STT3A was purchased from OriGene (RC201991; Rockville, 
MD). The cDNA clones for STT3B and MAGT1 were described previously (83). The 
TUSC3 gene was cloned by PCR from 293T cDNA. The sgRNA-resistant STT3A, 
STT3B, and MAGT1 constructs were made using overlap extension PCR to introduce 
silent mutations either modifying the CRISPR protospacer adjacent motif or sgRNA 
basepair complementarity. Constructs encoding catalytically inactive STT3B, STT3B, 
MAGT1, and TUSC3 were generated using overlap extension PCR. These constructs 
were cloned into the lentiviral expression vector pSMPUW (Cell Biolabs, San Diego, CA). 
The constructs for expression of pSAP and SHBG have been previously described (133, 
134). The pNS1-flag, pNS1-NS2A-V5, and pNS4B-HA constructs were generated by 
PCR using pD2/IC-30P-NBX as a template (135). Detailed descriptions of construction 
of these plasmids are available upon request. 
Lentiviral expression constructs were used to generate VSV-G pseudotyped 
lentiviruses and for stable transduction of target cells as described in (136). Knockouts 
and expression were confirmed by Western blot. 
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Viruses 
The infectious cDNA clone pD2/IC-30P-NBX encoding Dengue virus serotype 2 
strain 16681 was used to generate full-length viral RNA, and for construction of a 
reporter virus and replicon (135). In brief, the luciferase reporter virus luc-DENV was 
generated by overlap extension PCR, by fusion of a Renilla luciferase (Rluc) with C-
terminal self-cleaving 2A peptide to the DENV capsid in a pD2/IC-30P-NBX background. 
The luciferase reporter replicon was generated as previously described(137). To 
generate wild-type DENV-2 virus, the pD2/IC-30P-NBX plasmid was linearized with 
XbaI (New England Biolabs, Ipswich, MA), in vitro transcribed, and capped with the 
m7G(5’)ppp(5’)A cap analog (New England Biolabs) using T7 Megascript (Thermo 
Fisher Scientific, Waltham, MA). This RNA was transfected into Vero cells using TransIT 
mRNA reagent (Mirus Bio, Madison, WI). One week post-transfection, supernatant from 
transfected cells was 0.45 µm filtered and buffered with 20 mM HEPES. Cells were 
infected by replacing media on the cells with viral supernatant for 4 hr at 37C and 5% 
CO2. Afterwards, unbound virus was aspirated and replaced with fresh media. For 
luciferase reporter assays, cells were infected with the luciferase reporter virus luc-
DENV at an MOI = 0.1 for 2 or 3 d and luciferase activity was measured with the Renilla 
Luciferase Assay System (Promega, Madison, WI) and a Synergy 2 plate reader 
(BioTek, Winooski, VT). 
The recombinant infectious viruses used were as follows: 
SINV-GFP, generated from pTE/5’2J/GFP (138), YFV-Venus, generated from pYF17D-
5′C25Venus2AUbi (139), WNV-GFP, generated from pBELO-WNV-GFP-RZ ic (140), 
CHIKV-GFP generated from pCHIKV-LR 5′GFP (141), VEEV-GFP, a TC83 vaccine 
strain derivative generated from pVEEV/GFP (142), and DENV2-GFP a 16681 strain 
derivative generated from pDENV2-ICP30P-A-EGFP-P2AUb (143). Viral stocks were 
generated by electroporation of in vitro-transcribed RNA into WHO Vero cells (for 
DENV2-GFP) and BHK-21 cells (for SINV, YFV, WNV, CHIKV and VEEV). Zika virus 
(ZIKV), 2015 Puerto Rican PRVABC59 strain (144), was obtained from the CDC and 
passaged twice in Huh-7.5 cells.  
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Multiplicity of infection (MOI) was based on titers obtained on BHK-J cells for 
SINV, WNV, YFV and VEEV infections, and on Huh-7.5 cells for ZIKV. Titers were not 
available for YFV, CHIKV and DENV2, therefore different dilutions of viral stocks were 
tested.  
Cells were seeded in a 24-well plate at 5x104 cells/well for ZIKV or at 1x105 
cells/well for other viruses. The next day, cells were infected for 90 min at 37˚C in 2% 
FBS/PBS using a MOI of 1 for SINV, 0.01 and 0.001 for WNV and 0.8 for VEEV. We 
used a 1:4 dilution for YFV, 1:10000 for CHIKV and 1:5 for DENV-2. Virus inoculum was 
removed, fresh complete media was added to the cells, and infections allowed to 
proceed for 10 h for SINV and VEEV, 24 h for CHIKV, 33 h for YFV, 48 h and 72 h for 
WNV, 58 h for DENV-2 and 48 h and 96 h for ZIKV. Experiments with WNV and CHIKV 
were carried out under biosafety level 3 containment. Infected cells were detached 
using Accumax Cell Aggregate Dissociation Medium (eBiosciences). Cells were 
pelleted, fixed in 2% paraformaldehyde and permeabilized using Cytofix/Cytoperm (BD 
Biosciences). For ZIKV infected cells, E protein expression was detected with the 4G2 
monoclonal antibody (1:500 dilution), followed by incubation with Alexa Fluor 488-
conjugated anti-mouse IgG antibody (Invitrogen) at 1:1,000 dilution. All samples were 
resuspended in 2% FBS/PBS. Fluorescence was monitored by FACS using an LSRII 
flow cytometer (BD Biosciences). Data were analyzed with FlowJo Software. 
 
Antibodies 
Western blots were performed using antibodies against STT3A (12034-1-AP), STT3B 
(15323-1-AP), MAGT1 (17430-1-AP), and proSaposin (10801-1-AP) from the 
Proteintech Group (Rosemont, IL). Antibodies against TUSC3 (SAB4503183) and Actin 
(A5316) were purchased from Sigma Aldrich (St. Louis, MO). The antibody against 
EMC3 (sc-365903) was purchased from Santa Cruz Biotechnology (Dallas, TX). The 
antibody against SHBG (MAB2656) was purchased from R&D systems (Minneapolis, 
MN). The antibody against HA (C29F4) was acquired from Cell Signaling Technology 
(Danvers, MA). The anti-V5 antibody (R960-25) was purchased from Thermo Fisher 
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Scientific. The anti-NS1 monoclonal antibody 1F11 was a gift from the Dr. Malasit at the 
National Center for Genetic Engineering and Biotechnology in Thailand. 
 
Western blotting 
Cells were lysed in a buffer containing 20mM Tris pH 7.5, 100mM NaCl, 1% NP-40, 
10% glycerol, and 1mM EDTA with the addition of Halt protease inhibitor (Thermo 
Fisher). Lysates were cleared by centrifugation at 10,000 rpm for 10 minutes at 4C. LDS 
sample buffer was added and lysates were resolved by SDS-PAGE on 4-12% Bis-Tris 
NuPAGE Novex gels. Proteins were transferred to PVDF membranes, which were then 
blocked for 30 min in 5% nonfat dry milk in TBST. Antibodies were added at the 
following dilutions: STT3A (1:1000), STT3B (1:500), MAGT1 (1:1000), TUSC3 (1:1000), 
β-actin (1:20000), HA (1:1000), V5 (1:5000), NS1 (1: 100). Membranes were incubated 
in primary antibody overnight at 4˚C, then subsequently washed 3x with TBST for 15 
min each. Membranes were then incubated in blocking buffer with 1:500 of secondary 
HRP conjugated antibodies (ThermoFisher) for 1 h at room temperature. Blots were 
then washed and proteins were detected by the addition of SuperSignal West Femto 
substrate and immediate visualization on a LI-COR (Lincoln, Nebraska) imager or by X-
ray film. 
 
APEX labeling and immunoprecipitation 
The APEX2-MAGT1 fusion construct was generated by overlap extension PCR. APEX2-
mediated biotinylation and enrichment of biotinylated proteins was performed as 
previously described (145). A modification to the protocol was the addition of 20 mM N-
ethylmaleimide (NEM; Sigma Aldrich) to the lysis buffer to preserve native disulfide 
bonds. 10% of the lysates were reserved to be run as input controls. 1 µg of either V5 or 
HA antibody was added to immunoprecipitate respectively tagged proteins. Mixtures 
were rotated for 2 h at 4˚C. 5 µl of Dynabeads protein G (ThermoFisher) were added to 
each tube and rotated for 1 h at 4˚C. Complexes were washed 3x in 1x PBS with 0.1% 
Triton X-100. Proteins were eluted in 1x LDS sample buffer with 50mM Tris(2-
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carboxyethyl)phosphine hydrochloride (TCEP, Sigma Aldrich). Lysates were then 
subjected to SDS-PAGE and Western blotting as described above. 
 
Pulse-chase analysis of NS1 glycosylation 
HEK293 cells were grown to 60% confluency in 60 mm dishes and transfected with 6 µg 
of NS1-FLAG expression plasmids using Lipofectamine 2000 (ThermoFisher) in Opti-
MEM (ThermoFisher) according to the manufacturer’s instruction. After 24 h, NS1 
substrates were labeled with Tran35S label (Perkin Elmer, Waltham, MA) by incubation 
in methionine- and cysteine free media containing 10% dialyzed FBS for 20 min before 
the addition of 200 μCi/mL of Tran35S label. Cells were labeled for 5 min, then 3.7 mM 
unlabeled methionine and 0.75 mM unlabeled cysteine were added and cells were 
incubated for an additional 20 min. Cells were lysed at 4°C by a 30 min incubation with 
1 mL of RIPA lysis buffer. Lysates were clarified by centrifugation (2 min at 13,000 rpm) 
and precleared by incubation for 2 h with rabbit IgG and a mixture of protein A/G 
Sepharose beads (Santa Cruz Biotechnology) before an overnight incubation with anti-
FLAG antibody (Sigma Aldrich). Immunoprecipitates were collected with protein A/G–
Sepharose beads then washed five times with RIPA lysis buffer and twice with 10 mM 
Tris-HCl, pH 7.5 before eluting proteins with gel loading buffer. Where indicated, 
immunoprecipitated proteins were digested with Endoglycosidase H (New England 
Biolabs). Dry gels were exposed to a phosphor screen (Fujifilm, Valhalla, NY), and 
scanned with a Typhoon FLA9000 laser scanner (GE Healthcare, Chicago, IL).  
 
PNGase F digestion and maleimide-PEG assays 
Lysates were subjected to PNGase F (New England Biolabs) digestion as suggested by 
the manufacturer guidelines. Methoxypolyethylene glycol maleimide 5000 (mPEG; 
Sigma Aldrich) was dissolved in water to a 100 mM stock immediately prior to use. Cells 
were lysed in lysis buffer with the addition of either 20 mM NEM, 5 mM mPEG, or 0.5 
mM TCEP. Lysates were incubated at room temperature for 30 min prior to clearing by 
centrifugation at 10,000 rpm for 10 min. Supernatants with TCEP added were then 
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supplemented with 5 mM mPEG to modify the now reduced cysteines. Lysates were 
resolved by SDS-PAGE and visualized by Western blot as described above.  
 
Half-life quantification and band densitometry 
Cells were transfected in 6-well plates, then four hours later trypsinized and plated in 6 
wells of a 12-well plate. 24 hours post-transfection, media was replaced with fresh 
media containing 40 µg/ml cycloheximide (Cell Signaling Technology). Cells were lysed 
at various time points after cycloheximide treatment in RIPA buffer, and lysates were 
subjected to Western blot analysis as described. Band densities were quantified using 
LI-COR Image Studio (LI-COR, Lincoln, NE).  
 
Immunofluorescence 
Huh 7.5.1 cells were plated on poly-D-lysine coated coverslips and infected with DENV-
2 at an MOI = 0.1 or mock infected. Two days post-infection, cells were fixed in ice cold 
methanol for 1 h at -20C. Immunostaining with anti-HA (1:200) and anti-NS1 (1:50) 
antibodies was performed as described previously(146). 
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Figure 2.1. The CRISPR-Cas9 screen reveals the oligosaccharyltransferase complex as 
essential to DENV propagation. A, Depiction of the whole-genome CRISPR screen selecting 
for knockout cells resistant to dengue virus infection. B, Diagram of the two OST complexes that 
contain either STT3A or STT3B. Subunits of the OST complex shaded in blue were significantly 
enriched in the screen. C, Table of the hits from the screen showing the gene ID, p-value, and 
false discovery rate as calculated by MaGECK analysis. 
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Figure 2.2. Multiple ER resident complexes are necessary for DENV propagation. 
MaGeCK analysis for the top 200 ranked genes from the screen were plotted, with the gene 
name plotted on the X-axis and 1- false discovery rate (FDR) on the Y-axis. The top ranked hits 
are indicated in red and labeled with their gene names.  
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Figure 2.3. The catalytic activities of STT3A or STT3B are not required for DENV 
replication. A, Huh 7.5.1 cells were transduced with a lentivirus encoding a puromycin 
resistance marker, Cas9, and a single guide RNA (sgRNA) targeting the indicated genes. The 
sgRNAs targeting GFP act as a negative control. Two independent sgRNAs (indicated below 
the bars as “1” or “2”) were used per target gene to generate knockout cell pools. Cells were 
infected with luc-DENV for 3 days and luciferase activity was measured in relative light units 
(RLU). Below, Western blots for the indicated proteins are shown. Arrows indicate non-specific 
bands. B and C, knockout cell pools were transduced with lentiviral vectors to rescue 
expression of the indicated protein. “STT3A dead” is a catalytically inactive W526A/D527A 
double mutant. “STT3B dead” is a catalytically inactive W605A/D606A double mutant with a C-
terminal V5 tag. Transient transfection of constructs to express pSAP and SHBG were used to 
assess STT3A and STT3B catalytic activity. Below, Western blots show the expression of the 
indicated proteins. D, knockout cell pools were transiently transfected with a luc-DENV replicon 
and luciferase activity was measured at 4, 48, and 72 hours post-transfection (hpt). Data is 
plotted as a ratio of RLU / 4 hpt to control for transfection efficiency. GDD indicates a 
polymerase dead replicon with replacement of the GNN active site sequence in the NS5 RNA 
polymerase by GDD. E, cell viability for knockout cell pools was measured by Cell-Titer Glo over 
the course of 4 days for 3 independent wells. Data are normalized to day 1 values. P indicates 
the parental Huh7.5.1 cells. For A-E, data are expressed as means with SD for three 
independent biological replicates. In A-D, statistical significance was determined by Student’s t-
test, where *p<0.05, **p<0.005, and ***p<0.0005. In A, means were compared to GFP sgRNA 
#2. In B and C, means were compared to their respective knockouts. In D, means were 
compared to the GFP control.  
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Figure 2.4. Inhibition of flavivirus infection in OST knockout cells. Huh 7.5.1 cells were 
transduced to express two independent sgRNAs targeting STT3A, STT3B, or one sgRNA 
targeting GFP as a control. Stably transduced cell pools were then infected with the indicated 
fluorescent protein-expressing reporter viruses (see Materials and Methods for detailed 
description of the viruses) and subjected to flow cytometry to measure the number of infected 
cells. ZIKV infection was detected by immunostaining followed by flow cytometry. Data are 
plotted as a percentage relative to control cells expressing an sgRNA targeting GFP for three 
independent infections. Statistical significance was determined by Student’s t-test, where means 
were compared to GFP control, and  *p<0.05, **p<0.005, and ***p<0.0005. 
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Figure 2.5. The oxidoreductase activity of MAGT1 is required for DENV replication. A, 
CRISPR modified Huh 7.5.1 MAGT1 knockout cell pools were transduced to express MAGT1 or 
TUSC3-HA. The AxxA MAGT1 and TUSC3-HA mutants were generated by mutating CxxC 
active sites to AxxA. Below, Western blots for the indicated proteins are shown. The MAGT1 
antibody cross-reacts weakly with TUSC3. B, MAGT1 knockout cells were transduced to 
express MAGT1 mutants with the indicated mutations. Below, Western blots for the indicated 
proteins are shown. For A and B, cells were infected with luc-DENV and luciferase activity was 
measured at 3 days post-infection. C, immunofluorescence localization of MAGT1 in uninfected 
cells or two days post-infection with DENV. MAGT1 knockout cells were stably transduced to 
express HA tagged MAGT1 (WT or AxxA), as indicated on the left. Cells were fixed, 
permeabilized, and stained with antibodies to the indicated proteins. D, 293T cells expressing 
the indicated MAGT1-HA mutants were transfected to express STT3B-V5. Cells were lysed and 
co-immunoprecipitation was carried out using an anti-HA antibody. Shown are Western blots 
detecting the specified proteins. Mutants of MAGT1 migrate as two distinct bands. Data in 
panels A and B are expressed as means with SD for three independent infections. Statistical 
significance was determined by Student’s t-test, where *p<0.05, **p<0.005, and ***p<0.0005 
compared to MAGT1 knockout cells without any additions (lane 2).   
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Figure 2.6. NS1 glycosylation and dimerization are unchanged in the absence of STT3A, 
STT3B, or MAGT1. A, the indicated CRISPR knockout 293T cells were transfected to express 
NS1-FLAG. Lysates were treated with PNGase F to remove N-linked glycans followed by 
Western blotting to visualize differences in migration of NS1. The glycosylated and de-
glycosylated forms of NS1 are indicated. B, A 5 min pulse with 35S-cysteine/methionine was 
followed by a 20 min chase to visualize differences in the efficiency of NS1 glycosylation and 
dimerization in CRISPR-edited HEK293 cells. Endoglycosidase H treatment was used to 
indicate the mobility of unglycosylated NS1 by SDS-PAGE.  
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Figure 2.7. Effect of STT3B on NS4B glycosylation and biosynthesis. A, CRISPR modified 
STT3B knockout 293T cell pools were stably transduced to express either wild-type STT3B or 
STT3B-dead. Cells were transfected to express NS4B-HA, and lysates were resolved by SDS-
PAGE and visualized by Western blotting for the indicated proteins. B, Huh 7.5.1 cell pools 
ablated for the indicated genes were transfected to express NS4B-V5 (lanes 1-6) or were mock 
transfected (lanes 7-12). Lysates were subjected to PNGase F treatment in lanes 3-6 and 10-12 
to remove N-linked glycans from proteins, Proteins were resolved by SDS-PAGE and visualized 
by Western blotting for the indicated proteins. The black arrows indicate nonspecific background 
bands, and asterisks (*) mark the NS4B specific PNGase F sensitive bands. B, the indicated 
293T cells were co-transfected to express NS4B-HA and either NS1 or GFP (as transfection 
controls), and then lysed. Lysates were treated with PNGase F to facilitate quantitation of NS4B 
protein by removing N-glycans and Western blotting was performed for the indicated proteins. 
Chemiluminescent band intensities were quantified as NS4B-HA in STT3B knockout cells 
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relative to NS4B-HA in WT cells compared to the same ratio of GFP or NS1 to control for 
transfection efficiency. Each point plotted is the quantification of an independent transfection 
where the open triangles are compared to co-transfection with a plasmid expressing NS1 and 
closed circles with GFP. The mean and SD plotted are for all points. C, the indicated 293T cells 
were transiently transfected to express NS4B-HA and treated with cycloheximide 24 hours post-
transfection to block further translation. Cells were lysed at the indicated times post-
cycloheximide treatment and proteins were resolved by Western blotting. To the left are 
representative blots. The decay curves for 3 independent experiments are shown on the right.  
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Figure 2.8. MAGT1 is in close proximity to NS4B and NS1 during DENV infection. 
Huh7.5.1 cells stably transduced to express APEX2-MAGT1 were infected with DENV-2 or 
mock infected for 2 days. In all conditions, biotin-phenol was added to the cell media for 30 min. 
Where indicated, APEX2 was activated with hydrogen peroxide for 1 min to biotinylate APEX2-
MAGT1 proximal proteins prior to quenching and lysis. The far right lane is a negative control 
where APEX2 was not activated. Biotinylated proteins were immunoprecipitated with 
streptavidin beads, and lysates were resolved by SDS-PAGE. Western blotting was performed 
for the indicated proteins for both the IP samples and the input. 
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Figure 2.9. The redox status of NS4B is unchanged in the absence of MAGT1. 
The indicated CRISPR knockout 293T cells were transfected to express pNS4B-HA. We used 
STT3B knockout cells to deplete both MAGT1 and TUSC3. Cells were lysed in buffer with the 
specified additions of NEM, mPEG, or TCEP. Western blots were carried out to determine the 
migration patterns of NS1 and NS4B in the given conditions. The number of estimated 
maleimide-PEG modifications is indicated on the right. 
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Figure 2.10. A potential model for disulfide isomerization by single-cysteine MAGT1. A 
MAGT1 mutant containing a single cysteine active site (AxxC or CxxA) is shown in yellow. In 
blue is a target protein, such as NS4B, which contains multiple cysteines that may form disulfide 
bonds. This protein has a non-native disulfide arrangement that is identified by MAGT1. 
Through its active site cysteine, MAGT1 forms a mixed disulfide with the target protein, reducing 
the incorrect disulfide bond. The correct disulfide bond is then formed by a cysteine from the 
target protein, resolving the mixed disulfide between MAGT1 and its target. 
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Table 2.1. List of hits from this and other CRISPR screens. A list of the top 25 significant 
hits from biological replicates were compared to hits from two previously published screens. 
Gene names are colored to indicate groups of ER complexes. Yellow indicates genes encoding 
components of the EMC complex, blue indicates components of the OST complexes, and green 
indicates components of the ER associated degradation pathway (ERAD). The rank of each hit 
in independent biological replicates is shown in the second and third columns. The false 
discovery rate calculated by MAGeCK and the number of sgRNAs classified as a hit by 
MaGECK in our screen are shown. Hits from our screen that were also identified in the top 25 
hits of Marceau et al. or the top 150 of Savidis et al. are marked with an X.  
ID 
1st 
rank 2nd rank 1st FDR sgRNAs 
Top 25 
Marceau et al. 
Top 150 
Savidis et al.  
EMC6 1 2 0.00045 6 x x 
STT3A 2 11 0.00045 6 x x 
MAGT1 3 5 0.00045 6 x 
 STT3B 4 3 0.00045 5 x 
 UBE2J1 5 16 0.00045 6 
  EMC3 6 12 0.00045 6 x x 
EMC4 7 17 0.00045 6 x x 
EMC5 8 4 0.00045 5 x x 
EMC1 9 13 0.00045 6 x x 
EMC2 10 7 0.00045 4 x x 
RPN2 11 9 0.00045 5 x x 
APOB 12 10 0.002063 5 
  SSR2 15 20 0.015161 4 x 
 SSR3 16 14 0.015161 4 x 
 HSPA13 17 15 0.033489 4 x 
 OST4 18 18 0.058581 3 x 
 PRKRA 19 50 0.075 3 
  UBE2G2 20 1 0.075 4 
  SEC61B 22 6 0.083483 5 
 
x 
SSR4 25 48 0.121668 4 
  SYVN1 26 8 0.121668 4 
  RRBP1 30 21 0.21086 4 
  OSTC (DC2) 53 19 0.570164 3 x 
 DERL2 74 84 0.768196 4 
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Table 2.2. List of guide RNA sequences for OST knockouts. Oligonucleotides were cloned 
into pLENTICRISPRv2 to generate lentiviruses for CRISPR mediated knockout of specific OST 
genes. 
crRNA sequence Comment 
ACAGACATTCCGAATGTCGA STT3A-1 
AAGGTGGTACGTGACGATGG STT3A-2 
GATGTAAGGCCGCTAAAAGT STT3B-1 
CCAGCGGTTATCATCAACCC STT3B-2  
GAGCGAACATGGCAGCGCGT MAGT1-1 Forward 
AGCAGTGAACATGACGATAA MAGT1-2 Forward 
GGGCGAGGAGCTGTTCACCG EGFP-1 from Addgene 
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CHAPTER III 
The EMC promotes stable expression of DENV and ZIKV non-structural multi-
pass transmembrane proteins to support virus infection 
 
 At the time of writing, the majority of this chapter was submitted to Cell Reports 
for peer review and publication, written by David L. Lin, Takamasa Inoue, Yu-Jie Chen, 
Aaron Chang, Billy Tsai, and Andrew W. Tai in 2018. 
 Takamasa Inoue, Yu-Jie Chen, and Aaron Chang performed experiments to 
show that expression of ZIKV NS4A and NS4B depend on the EMC, and that NS4B 
ubiquitination is p97 dependent. 
 
The EMC is necessary for DENV replication 
The six core subunits of the EMC, EMC1 through EMC6, were identified as host 
dependency factors for flavivirus infection in four independent screens (12, 24-26). We 
validated that these EMC subunits were indeed necessary for DENV infection by first 
generating pooled EMC knockout Huh 7.5.1 cells using CRISPR/Cas9 technology. We 
found that knockout cells lacking EMC subunits 1, 2, 4, 5, or 6 were significantly 
reduced in their ability to support DENV infection compared to wild-type control cells 
(Figure 3.1A). 
Using a transient replication assay with a luciferase reporter DENV subgenomic 
replicon, we found that EMC6 knockout cells supported significantly reduced levels of 
DENV replication (Figure 3.1B). These data corroborate previous findings, suggesting 
that EMC depletion inhibits the initial stages of replication (25). By contrast, hepatitis C 
virus (HCV) infection does not require the EMC (Figure 3.2), demonstrating specificity of 
viral inhibition by EMC knockout.   
 48 
We also confirmed that long-term EMC6 depletion leads to the loss of other EMC 
subunits (Figure 3.1C)(107, 147) without affecting their mRNA levels (Figure 3.3), 
suggesting that EMC6 is required for the stability of the other EMC subunits. Exogenous 
expression of a sgRNA-resistant EMC6 construct in EMC6 knockout cells fully restored 
their ability to support DENV infection, as well as the expression of the other EMC 
subunits (Figure 3.1C). Collectively, these results demonstrate that the EMC is required 
to support DENV infection. 
 
The EMC is necessary for expression of flavivirus NS4A and NS4B 
The EMC has been shown to act as a multi-pass transmembrane chaperone 
(100, 105, 106), and has been proposed to function as a transmembrane insertase 
(107). As the DENV genome encodes several multi-pass transmembrane NS proteins 
(NS2A, NS2B, NS4A, and NS4B), we hypothesized that the EMC is necessary for the 
biogenesis of one or more of these NS proteins. To test this, we transfected wild-type 
and EMC knockout cells to individually express each of the multi-pass transmembrane 
DENV NS proteins, and assessed the expression level of each of the proteins by 
immunoblotting. Strikingly, expression of both DENV NS4A and NS4B were significantly 
reduced in EMC knockout cells compared to wild-type cells (Figures 3.4A and B; 
quantified in E). By contrast, expression of NS2B was moderately decreased in EMC 
knockout cells when compared to wild-type cells (Figure 3.4C, quantified in E), while 
NS2A expression was unaffected by the loss of the EMC (Figure 3.4D, quantified in E). 
As expected, expression of either soluble NS1 or GFP was also unaffected by the loss 
of the EMC (Figure 3.4A-E).  
To generalize these findings to other flavivirus family members, we performed 
similar experiments for ZIKV non-structural proteins. As with EMC6 knockout, EMC1 
knockdown in HEK 293T cells by siRNA also led to depletion of the other EMC subunits 
(Figure 3.6). We next transfected wild-type (scrambled siRNA-treated) and EMC1 
knockdown cells to express a full-length replication-defective ZIKV polyprotein, and 
observed a similar reduction in the expression level of NS4B in EMC knockdown cells 
(Figure 3.4F). However, expression of the viral E protein from the same polyprotein was 
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unaffected by loss of the EMC, despite also being a multi-pass transmembrane protein 
(Figure 3.4F). In addition to using the full-length replication-defective ZIKV polyprotein, 
we also expressed individual ZIKV non-structural proteins. Using this approach, 
expression of both NS4A and NS4B was significantly reduced in EMC knockdown cells 
(Figure 3.4H and I), whereas expression of GFP or the multi-pass ER membrane protein 
BAP31 was unaffected by EMC1 depletion. Interestingly, in contrast to DENV NS2B, 
expression of ZIKV NS2B was also markedly decreased when EMC1 was knocked 
down (Figure 3.4G), suggesting a difference in EMC dependency for this NS protein. 
Taken together, these data suggest that the EMC supports the expression of flavivirus 
NS proteins, which are necessary for viral replication. 
 
The EMC interacts with flavivirus NS4B 
We next performed co-immunoprecipitation (co-IP) experiments using an 
antibody targeting endogenous EMC4 in cells stably expressing a DENV replicon. Our 
results revealed that NS4B, but not NS1 or NS2B, significantly co-immunoprecipitated 
with endogenous EMC4 (Figure 3.4J). Additionally, affinity purification of transfected S-
tagged ZIKV NS4B (but not the control S-tagged GFP) co-precipitated with endogenous 
EMC1 and EMC2 (Figure 3.4K). These results demonstrate that the EMC binds to 
DENV/ZIKV NS4B. 
To further corroborate the physical interaction data, we asked if the EMC might 
co-localize with the viral NS proteins in cells. To test this, we transduced DENV replicon 
cells to express FLAG tagged EMC4, then performed immunofluorescence staining and 
confocal microscopy to visualize localization of the EMC in DENV infected cells. We 
found strong colocalization of EMC4 with puncta containing NS4A and NS4B (Figure 
3.4L). By contrast, EMC4 was diffusely distributed in cells with little NS4A or NS4B 
staining, suggesting that the EMC is recruited to the DENV replication organelle. These 
data are consistent with our finding that the EMC interacts with NS4B during DENV 
replication. Alternatively, we also co-stained DENV replicon cells with NS4B and 
calnexin, another ER-resident protein, and found that calnexin was not recruited in the 
same fashion to NS4B positive sites, further reinforcing a role for the EMC at the 
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replicase (Figure 3.5). Collectively, the evidence supports a model where the EMC is 
required for flavivirus infection by recruitment to the viral replication organelle, where it 
directly interacts with NS4A and NS4B to promote their stability. 
 
Mapping determinants of EMC dependence 
 Given that NS4B engages the EMC, we next sought to identify the specific 
determinants of NS4B that confer its dependence on the EMC. In addition to its 
postulated role as a molecular chaperone for multi-pass transmembrane proteins, the 
EMC also has been shown to function as an insertase for tail-anchored transmembrane 
proteins, particularly those with weakly hydrophobic transmembrane domains (107). 
Therefore, we hypothesized that weakly hydrophobic transmembrane domains in NS4A 
and NS4B might drive their EMC dependence. DENV NS4B harbors an N-terminal 2k 
signal peptide that is co-translationally cleaved, followed by five predicted hydrophobic 
helices (Figure 3.7A). Evidence suggests that the three C-terminal helices are 
membrane-spanning domains (66, 68, 69). By contrast, the first two N-terminal helices 
have relatively poor hydrophobicity (Figure 3A, pTM1 and pTM2), with one report 
suggesting that these domains lie on the ER lumenal membrane rather than spanning 
the lipid bilayer (66). Transmembrane prediction by TMHMM also revealed that the two 
N-terminal helices exhibit relatively low transmembrane probabilities compared to the 
three C-terminal helices (Figure 3.7B). 
 By analogy to tail-anchored transmembrane domains, we hypothesized that the 
two N-terminal marginally hydrophobic helices in NS4B are targets of EMC activity. To 
test this idea, we generated plasmids encoding a wild-type DENV 2k-NS4B-GFP fusion 
protein, a mutant lacking these two helices (Δ32-96), or harboring one or two of the N-
terminal hydrophobic segments immediately following the 2k signal sequence (2k-58 
and 2k-96) (Figure 3.7A). We co-transfected these plasmids along with NS1-FLAG as a 
transfection control into wild-type or EMC knockout cells, and assessed their relative 
levels of expression by immunoblotting. Consistent with previous results, NS4B 
expression was significantly reduced in EMC knockout cells compared to wild-type cells 
(Figure 3.7C). However, expression of a GFP tagged or HA tagged NS4B(Δ32-96) 
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mutant was unaffected by EMC knockout, indicating that loss of these helices rendered 
NS4B expression independent of the EMC (Figure 3.7C; quantified in D). By contrast, 
neither NS4B (2k-96) nor NS4B(2k-58) displayed strong EMC dependency when fused 
to GFP (Figure 3.7C), suggesting that the N-terminal helices of NS4B are not sufficient 
for EMC dependence. Thus, our results are consistent with the idea that the two N-
terminal marginally hydrophobic helices in NS4B are required for recognition by the 
EMC. 
 
Hydrophobicity as a determinant of EMC dependence 
 As the Δ32-96 NS4B mutant was insensitive to EMC depletion, we hypothesized 
that specific mutations to amino acids 32-96, domains containing the two marginally 
hydrophobic helices, of NS4B could recapitulate the same phenotype. We generated 
NS4B mutants to swap the hydrophobic residues in pTM1 and pTM2 for lysine to render 
the domains hydrophilic (Figure 3.8). Similarly, we swapped the polar and charged 
residues in both domains to leucine, generating more canonical hydrophobic 
transmembrane domains (Figure 3.8). We transfected WT and EMC knockout cells to 
express these constructs, then performed Western blots, and quantified their expression 
levels.  
 Notably, we found that the glycosylation patterns were significantly different 
between the mutants. Two glycosylation sites between pTM1 and pTM2, which we 
found are heavily glycosylated when pTM1 and pTM2 are mutated to increase its 
hydrophilicity, driving pTM1 and pTM2 into the ER lumen. Indeed, we find that the 
pTM1+pTM2-to-lysine mutant is highly glycosylated (Figure 3.9). Interestingly, pTM1-to-
lysine is heavily glycosylated in wild-type cells, but not in EMC knockout cells (Figure 
3.8 and 3.9A). None of the leucine swapped mutants were glycosylated as heavily as 
the wild-type protein. This data reinforces a model where insertion of pTM1 and pTM2 
into the membrane will force the sequons into the cytosolic side of NS4B, where the 
loop between pTM1 and pTM2 is inaccessible to the ER N-glycosylation machinery 
(Figure 3.8 and 3.9B). 
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We found that mutation of either of the transmembrane domains individually was 
insufficient to drive complete EMC independence (Figure 3.9A-C). We quantified 
expression levels of each mutant in wild-type and EMC6 knockout cells using band 
densitometry. Quantification of proteins after PNGase treatment or pre-treatment using 
this method yielded highly similar results (Figure 3.9C). Mutation of pTM1 and pTM2 to 
lysine-rich hydrophilic domains slightly but significantly increased its independence on 
the EMC (Figure 3.9A and C). Mutation of pTM1 to leucine did not affect EMC 
dependence, while pTM2 to leucine slightly decreased dependence on the EMC (Figure 
3.9B and C). Strikingly, mutation of pTM1 and pTM2 to leucine-rich hydrophobic 
domains dramatically increased its expression in EMC knockout cells, and caused 
expression to be independent of the EMC (Figure 3.9B and C). Together, these results 
assert that EMC dependence of NS4B is driven by the marginal hydrophobicity of the 
first two putative transmembrane domains. 
 
NS4B is degraded via ERAD in the absence of the EMC 
 Finally, we clarified the fate of destabilized NS4B in the absence of the EMC. As 
NS4B expression is significantly reduced in EMC knockout/knockdown cells, we asked 
whether under this depleted condition, NS4B is targeted for proteasomal degradation 
via the ERAD pathway. To test this, we transduced wild-type and EMC knockout cells to 
express DENV NS4B-HA, treated them with the proteasome inhibitor MG132, and 
analyzed the cell lysates by immunoblotting. Importantly, NS4B-HA in EMC6 knockout 
cells accumulated to levels similar to that of wild-type cells after proteasomal inhibition 
(Figure 3.10A). This finding suggests that when NS4B is destabilized in the absence of 
the EMC, it retrotranslocates to the cytosol to be degraded by the proteasome. To 
further support a role of ERAD in disposing NS4B, we asked if this non-structural protein 
is in fact polyubiquitinated when the proteasome is inactivated; polyubiquitination of a 
misfolded ERAD substrate is required for targeting to the proteasome (148). Indeed, in 
cells treated with MG132, immunoprecipitated DENV NS4B-HA was polyubiquitinated 
(Figure 3.10B, left panels); a similar result was found for ZIKV NS4B-HA (Figure 3.10B, 
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right panels). These findings are consistent with an important role of ERAD in degrading 
NS4B when the integrity of the EMC is compromised. 
 p97 is an ATPase that normally extracts polyubiquitinated ERAD substrates out 
of the ER membrane and into the cytosol (149). Because our results implicated a role 
for ERAD in the removal of NS4B from EMC depleted cells, we asked whether p97 
plays a role in promoting flavivirus NS4B degradation in EMC-deficient cells. 
Accordingly, we co-transfected EMC1 knockdown cells with plasmids encoding wild-
type p97 or the dominant-negative p97(p97QQ) (150) along with NS4B from both DENV 
and ZIKV, and examined NS4B polyubiquitination. Our results demonstrated that in the 
presence of p97QQ, immunoprecipitated NS4B-HA displayed increased 
polyubiquitination when compared to cells expressing wild-type p97 (Figure 3.10C and 
D). These data provide further evidence that in EMC-depleted cells, flavivirus NS4B is 
misfolded, leading to ERAD recognition, ubiquitination, and proteasomal degradation. 
 
Alanine scanning and truncation analysis of EMC6 
EMC6 is highly conserved among metazoans, with no homology to proteins of 
known function. To date, biochemical analysis of individual EMC subunits has yet to be 
performed, and thus specific functions of each EMC subunit are unclear. Therefore, we 
next decided to ask whether EMC activity or assembly was dependent on specific 
EMC6 residues. We first performed alanine scanning in blocks of 5 consecutive amino 
acids, and complemented EMC6 knockout cells with C-terminal HA-tagged EMC6 
mutants (Figure 3.11). 
We confirmed expression of the EMC6 mutants and other EMC subunits by 
Western blot, and found that expression of any of the EMC6 mutants was sufficient to 
restore EMC2 or EMC4 expression (Figure 3.11), suggesting that complex assembly is 
not dependent on a single short contiguous stretch of EMC6 residues. Furthermore, we 
found that cells expressing any of the EMC6 alanine mutants supported significantly 
higher luc-DENV infection than cells expressing no EMC6 (Figure 3.11). This data 
suggests that, as for EMC assembly, that no single short contiguous amino acid stretch 
is necessary for EMC activity. 
 54 
Because alanine scanning did not reveal EMC6 functional motifs, we decided to 
generate truncation mutants to assess whether larger motifs of EMC6 are necessary for 
EMC activity and complex assembly. The C-terminus of EMC6 is highly conserved 
among metazoans. Cells expressing EMC6 with a 10 amino acid deletion at the C-
terminus were unable to support DENV infection despite partial rescue of EMC2 and 
EMC4 expression (Figure 3.12A). These data suggest that the C-terminus of EMC6 may 
be important for EMC activity. Further analysis of the EMC6 C-terminus will reveal 
whether these residues are critical for complex assembly and EMC activity. 
Furthermore, we found that expression of a 20 amino acid N-terminal EMC6 
deletion mutant restored EMC2 and EMC4 expression, and luc-DENV infection (Figure 
3.12B). Meanwhile, a 40 amino acid N-terminal deletion only minimally restored EMC2 
and EMC4 expression, and allowed for a partial but statistically significant rescue of 
DENV infection (Figure 3.12B). A 60 amino acid N-terminal EMC6 truncation did not 
express to detectable levels, and as expected did not restore DENV infection or EMC 
expression (Figure 3.12B). Together, these data suggest that the N terminus of EMC6 is 
not critical for its function in flavivirus replication or complex assembly. 
 
Discussion 
The infection cycles of flaviviruses depend on the ER. Flavivirus infection induces 
extensive remodeling of the ER membrane to form specialized replication organelles (17, 
151). These structures have been proposed to shield viral products, such as double-
stranded RNA, from innate immune recognition, and to concentrate factors that promote 
viral replication. We speculate that another function of these organelles is to generate a 
specialized environment for polyprotein translation, processing, and folding. The viral 
polyprotein is translated and processed at the ER, and it has been shown that the 
cytosolic capsid and NS5 proteins of DENV depend on Hsp70 chaperones for their 
stability (152). However, whether flaviviral membrane proteins also require cellular 
chaperones for their folding and stability remains unknown.  
The EMC has been identified as a host dependency factor for infection by the 
flaviviruses DENV, ZIKV, and YFV (12, 24-26). While the functions of the EMC remain 
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incompletely understood, accumulating evidence indicates that it acts as an ER-
localized molecular chaperone for a subset of multi-pass transmembrane proteins (100, 
105, 106), as well as a tail-anchored transmembrane protein insertase (107). As the 
EMC likely acts as a chaperone for multiple cellular membrane proteins, we cannot 
exclude the possibility that a cellular membrane protein essential for DENV and ZIKV 
infection is misfolded in EMC-depleted cells. For example, it has been suggested that 
the EMC is required for expression of a ZIKV entry factor (25). However, this does not 
exclude a role for the EMC in NS4A and NS4B folding. In fact, several lines of evidence 
argue that the EMC functions as a molecular chaperone for these viral proteins: (1) both 
are multi-pass transmembrane proteins expressed on the ER and thus are biologically 
plausible substrates; (2) the levels of both proteins are specifically reduced by EMC 
depletion and restored by ERAD/proteasome inhibition; (3) the EMC is recruited to viral 
replication sites in DENV-replicating cells lacking viral structural proteins; (4) NS4B 
interacts with the EMC by co-immunoprecipitation analysis.  
While expression of NS4A and NS4B are reduced in EMC knockout cells, other 
DENV NS proteins are relatively unaffected, as are at least some cellular multi-pass 
transmembrane proteins such as BAP31. While DENV NS2B was relatively unaffected 
by EMC knockout and did not co-precipitate with the EMC, expression of ZIKV NS2B 
was significantly reduced. This data lends the possibility that the EMC may be 
additionally required for expression of different NS proteins for each flavivirus. 
Furthermore, HCV does not depend on the EMC for infection despite encoding several 
multi-pass transmembrane proteins. This specificity invokes the obvious question: what 
are the determinants within multi-pass transmembrane proteins that drive EMC 
dependence? We showed that deletion of two marginally hydrophobic helices in NS4B 
leads to a loss of EMC dependence, consistent with the proposal that the EMC 
recognizes weakly hydrophobic segments in both multi-pass transmembrane and tail-
anchored membrane proteins. We speculate that the EMC mediates the native folding 
of specific proteins with marginally hydrophobic domains, and that in the absence of the 
EMC, these proteins are recognized by ERAD machinery as misfolded, and thus are 
degraded. 
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Our findings regarding EMC function are conceptually in agreement with a recent 
publication (Shurtleff et al, 2018) concluding, based on ribosome labeling and 
proteomics in yeast and human cells, that the EMC serves to stabilize multipass 
transmembrane proteins encoding transmembrane domains enriched for charged 
residues. However, there was no experimental demonstration that mutation of any 
putative EMC client could modulate its EMC dependence. Also very interesting was the 
finding that in EMC-depleted human cells, there was a surprisingly limited number of 
cellular proteins that displayed significant EMC dependence: only 11 proteins were 
decreased by 2-fold or more in both EMC2 and EMC4-depleted cells. Our work adds 
substantially to these findings by the experimental demonstration that the stability of 
NS4B in EMC-depleted cells depends on two marginally hydrophobic segments. 
Furthermore, the NS4A and NS4B proteins of both ZIKV and DENV display strong 
dependence on the EMC for their stability. This is consistent with cells being able to 
tolerate genetic depletion of EMC subunits while these flaviviruses are not. Finally, the 
EMC is recruited to sites of viral replication in DENV-replicating cells, consistent with a 
specific hijacking of this complex during viral infection. 
In summary, this work defines a mechanism by which the EMC supports 
flavivirus replication and provides additional evidence that the EMC functions as a multi-
pass transmembrane chaperone. The dependence of multiple flaviviruses on the EMC 
and on Hsp70 proteins highlights their dependence on ER quality control mechanisms 
and therefore a shared vulnerability that potentially could lead to broadly antiviral 
strategies. 
 
Materials and Methods 
Plasmids, sgRNAs, and siRNAs 
Individual sgRNAs were cloned into the pLENTICRISPRv2 vector for lentiviral 
transduction to generate EMC knockout cells (Table 3.1). For transient EMC knockdown, 
Thermo Fisher Predesigned Silencer™ siRNA against KIAA0090 (ID# 122746) was 
used as an EMC1 siRNA. Allstar negative control siRNA (Qiagen, Hilden, Germany) 
was used as a scrambled siRNA. 
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Constructs to express epitope tagged DENV non-structural proteins were 
generated by PCR using DENV serotype 2 strain 16681 cDNA clone pD2/IC-30P-NBX 
(135), then cloned into pSMPUW (Cell Biolabs, San Diego, CA) or pCDNA4 (Thermo 
Fisher Scientific) expression vectors. A full-length infectious cDNA clone of ZIKV from 
the 2015 Epidemic in Brazil (ZIKV-ICD) was a generous gift from Dr. A. Pletnev 
(National Institutes of Health, Bethesda, MD) (153). To construct a replication-defective 
cDNA clone of ZIKV, the NS5 catalytic G664-D665-D666 domain in ZIKV-ICD was 
mutated to G664-A665-A666 using standard cloning methods. To construct ZIKV non-
structural protein expression vectors, the corresponding cDNA sequences were 
amplified by PCR using ZIKV-ICD as template and inserted into pcDNA3.1(-) in frame 
with the S tag or S-tagged GFP sequence by standard cloning methods. To construct C-
terminal FLAG- or S-tagged GFP expression vectors, the GFP cDNA sequence was 
inserted into pcDNA3.1(-) in frame with the FLAG or S tag sequence by standard 
cloning methods. 
The WT and dominant negative QQ p97 expression vectors were generous gifts 
from Dr. Y. Ye (National Institutes of Health) (150). Epitope tagged EMC6 and EMC4 
were cloned by PCR using 293T cDNA as a template. Mutants of non-structural proteins 
were generated by overlap extension PCR. Detailed descriptions of these plasmid 
constructs are available upon request. Lentiviral expression constructs including 
pSMPUW and pLENTICRISPRv2 were also used to generate VSV-G pseudotyped 
lentiviral particles for transduction as previously described (136). 
 
Luciferase virus and replicon assays 
DENV serotype 2 strain 16681 cDNA clone pD2/IC-30P-NBX was used to 
generate the luciferase dengue reporter virus as previously described (24). The 
construction of the luciferase dengue reporter replicon has also been previously 
reported (146). Luciferase activity was measured using the Renilla luciferase assay 
system (Promega, Madison, WI). The transient replicon assay was performed as 
previously described (24). In brief, the luciferase dengue reporter replicon was in vitro 
transcribed and 5’ capped using T7 Megascript (Thermo Fisher Scientific). RNA was 
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then transfected into cells using TransIT mRNA reagent (Mirus Bio, Madison, WI). 
Luciferase activity was measured at 4 hours and 48 hours post-transfection. 
 
Western blotting and band densitometry 
 For DENV expression constructs, cells were lysed in buffer containing 50 mM 
Tris, 150 mM NaCl, 1 mM EDTA, 1% SDS, and 5% glycerol, and Halt protease inhibitor 
(Thermo Fisher Scientific) on ice for 10 min. Lysates were clarified by centrifugation at 
10k RCF for 10 min at 4˚C. LDS sample buffer (Thermo Fisher Scientific) was added to 
the lysate prior to loading the lysate on Bis-Tris NuPAGE Novex gels (Thermo Fisher 
Scientific). 
For ZIKV expression constructs, Flp-In™ T-REx™ 293 cells (Thermo Fisher 
Scientific) were reverse-transfected with the indicated siRNAs at 50 µM using 
Lipofectamine RNAi MAX (Thermo Fisher Scientific) and incubated in a 12-well plate. At 
48 h post siRNA transfection, cells were co-transfected with ZIKV constructs and GFP-
FLAG using PEI and incubated for 24 h. Alternatively, cells were transfected with a 
vector containing the replication-defective ZIKV-ICD cDNA clone and incubated for 48 h. 
Cells were then lysed with a buffer containing 50 mM HEPES, 150 mM NaCl, 1% Triton 
X-100, and 1 mM PMSF, and centrifuged at 16,100 x g for 10 min at 4 ºC. The resulting 
supernatants were subjected to SDS-PAGE. 
After electrophoresis, proteins were transferred to a PVDF membrane, then 
blocked in Tris-buffered saline pH 7.5 with 0.1% Tween-20 (TBST) with 5% BSA for 30 
min at room temperature. Primary antibodies were diluted in blocking buffer and 
incubated with the membrane at 4˚C overnight. Blots were washed three times with 
TBST for 10 min each, incubated in HRP-conjugated secondary antibody diluted in the 
same blocking buffer for 1 h, and washed again three times. Bands were visualized by 
chemiluminescent detection with SuperSignal West Femto (Thermo Fisher Scientific) 
substrate in a Syngene PXi 6 (Synoptics Limited, Cambridge, UK) imager or developed 
using traditional X-ray film methods. Band quantification was performed using ImageJ 
(NIH). 
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Antibodies 
Antibodies used for Western blotting, co-IP, and immunofluorescence are as 
follows: anti-HA C29F4 from Cell Signaling Technology (Danvers, MA), anti-HA 12CA5 
from Santa Cruz Biotechnology (Dallas, TX), anti-DENV-NS2B GTX124246 from Gentex 
(Irvine, CA), anti-DENV-NS4B GTX103349 from Genetex, anti-DENV-NS4A 
GTX124249 from Genetex, anti-ZIKV-NS4B GTX133311 from Genetex, anti-S tag 
AB19321 from Abcam (Cambridge, UK), anti-FLAG F1804 from Sigma Aldrich (St. Louis, 
MO), anti-p97 PA5-22257 from Thermo Fisher Scientific, anti-Ubiquitin P4D1 from 
Santa Cruz Biotechnology, anti-GFP D5.1 from Cell Signaling Technology, anti-EMC1 
AP10226b from Abgent (San Diego, CA), anti-EMC2 (TTC35) sc-166011 from Santa 
Cruz Biotechnology, anti-EMC3 (TMEM111) sc-365903 from Santa Cruz Biotechnology, 
anti-EMC4 PA5-48708 from Thermo Fisher Scientific, anti-EMC4 ab184162 
(EPR15081) from Abcam, anti-EMC6 ARP44679_P050 from Aviva Systems Biology 
(San Diego, CA), anti-Beta actin A5316 from Sigma Aldrich, anti-BAP31 CC-1 from 
Thermo Fisher Scientific. Anti-S tag agarose beads were used for affinity purification. 
The anti-NS1 monoclonal antibody was a gift from Dr. Malasit at the National Center for 
Genetic Engineering and Biotechnology in Thailand. The anti-E protein monoclonal 
antibody originated from hybridoma 4G2 supernatant. 
 
Proteasomal inhibition and co-immunoprecipitation 
For proteasome inhibition assays, MG132 (Sigma Aldrich) was added to the 
media at 10 µM for 6 h, then cells were lysed in RIPA buffer with 20 mM N-
ethylmaleimide (Sigma Aldrich) to inhibit deubiquitinase activity and Halt protease 
inhibitor, then subjected to IP by anti-HA antibody. 
For p97/VCP experiments, Flp-In™ T-REx™ 293 cells were reverse-transfected 
with EMC1 siRNA at 50 µM using Lipofectamine RNAi MAX and incubated in a 6-well 
plate. At 48 h post-transfection, cells were further co-transfected with the indicated 
flavivirus NS4B construct and either one of an empty vector, the WT or dominant 
negative p97QQ expression vector. Following incubation for 24 h, cells were harvested, 
lysed with a buffer containing 50 mM HEPES, 150 mM NaCl, 1% Triton X-100, and 1 
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mM PMSF, and centrifuged at 16,100 x g for 10 min at 4 ºC. To immunoprecipitate 
DENV NS4B-HA, the resulting supernatant fraction was incubated with the anti-HA 
monoclonal 12CA5 antibody at 4ºC for 2 h, followed by incubation with protein A/G 
agarose beads. Alternatively, to isolate ZIKV NS4B-S, whole cell lysates were incubated 
with S protein-conjugated beads at 4ºC for 2 h. After beads were extensively washed 
with a buffer containing 50 mM HEPES, 150 mM NaCl, and 1% Triton X-100, bound 
materials were eluted with SDS sample buffer followed by SDS-PAGE and Western 
blotting for detection. 
For Co-IP assays between the EMC and NS4B, cells were lysed in buffer 
containing 50 mM Tris, 150 mM NaCl, 1% Deoxy Big CHAP detergent (256455, EMD 
Millipore, Burlington, MA) and Halt protease inhibitor. Lysates were clarified by low 
speed centrifugation at 10,000 x  g for 10 min at 4˚C. The monoclonal antibody C29F4 
was added for HA immunoprecipitation. For endogenous EMC4 co-IP, the EMC4 
monoclonal antibody EPR15081 was added. After addition of antibody, samples were 
incubated at 4˚C for 1 h. Protein G Dynabeads (Thermo Fisher Scientific) were then 
added, and samples were again incubated at 4˚C for 1 h. Magnetically isolated beads 
and bound proteins were washed three times with PBS containing 0.1% Deoxy Big 
CHAP. Samples were eluted by addition of LDS sample buffer with 50 mM TCEP 
(Thermo Fisher Scientific) then heated to 95˚C for 10 min.  
 
Immunofluorescence microscopy 
 Huh 7.5.1 cells stably harboring a DENV replicon encoding puromycin resistance 
were stably transduced with a lentivirus encoding FLAG-EMC4 and blasticidin 
resistance. Cells were plated on poly-D-lysine coated coverslips then fixed in ice cold 
100% methanol for 20 minutes. Coverslips were washed in PBS, then blocked in PBS 
with 2% BSA and 0.1% Triton X-100 for 30 minutes. The same blocking buffer was used 
to dilute the indicated antibodies for immunostaining, and for secondary fluorophore 
conjugated antibody detection. 
 
Quantification and Statistical Methods 
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 For infection and replicon experiments, each dot represents an individual 
biological replicate, with bars representing the mean ± SD. For band densitometry, each 
dot represents an individual Western blot from an independent transfection. Statistics 
were calculated using Prism 7 (GraphPad Software). Statistical significance was 
determined by non-parametric Mann Whitney U test as indicated in the figure legends. 
For all figures, * p<0.05, ** p<0.005, and *** p<0.0005. 
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Figure 3.1. DENV requires the EMC for replication. In A-C, Huh 7.5.1 cells were stably 
transduced with pLentiCRISPRv2 lentiviral vectors encoding Cas9 nuclease and a targeting 
sgRNA to knock out the indicated gene, or a non-targeting (NT) control. In A, two independent 
sgRNAs were used per gene. Cells were then infected with a luciferase reporter DENV (luc-
DENV) and luciferase activity was measured 3 d post-infection. In B, cells expressing 3 different 
sgRNAs targeting EMC6 or a NT control were transfected with in vitro transcribed RNA 
encoding a luciferase reporter DENV replicon. Replication was assessed by the ratio between 
luciferase activity at 48 h vs 4 h post-transfection to control for differences in transfection and 
translation efficiency. In C, EMC6 knockout cells were transduced to express an sgRNA-
resistant HA tagged EMC6, then infected with luc-DENV and luciferase activity was measured 3 
d post-infection. Duplicate wells were lysed for immunoblotting with the indicated antibodies. For 
A-C, data are plotted as relative luciferase units as a percentage of NT. Each dot represents an 
independent infection, and bars show means ± SD relative to cells expressing a non-targeting 
sgRNA control. Statistical significance compared to NT was determined by Mann-Whitney U: *, 
p < 0.05, **, p < 0.005, ***, p < 0.0005. 
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Figure 3.2. Hepatitis C virus replication is unaffected by the loss of the EMC. Huh 7.5.1 
cells stably expressing Cas9 nuclease with either a non-targeting (NT) or EMC6 specific sgRNA 
were infected with HCV encoding a NanoLuc luciferase reporter followed by luciferase activity 
measurement 3 d later. Each dot represents a biological replicate with bars representing 
means±SD.  
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Figure 3.3. Transcription of EMC subunits is unaffected by EMC6 knockout. RNA was 
extracted from wild-type and EMC6 knockout Huh 7.5.1 cells, then subjected to reverse 
transcription and qPCR for the indicated genes. Each dot represents a biological replicate with 
bars showing means±SD.  
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Figure 3.4. Flavivirus NS4A and NS4B are dependent on the EMC for efficient expression. 
In A-D, 293T cell pools stably expressing Cas9 nuclease and a targeting sgRNA to knockout 
EMC6 were subsequently transiently cotransfected with constructs encoding HA-tagged DENV 
non-structural proteins and NS1-FLAG (A-C) or GFP (D) as a transfection control. In F-I, 293 
cells were transfected with siRNAs against EMC1 or a scrambled control (scr). 48 h later, cells 
were transfected with a replication-defective full-length ZIKV cDNA in F or to express the 
indicated S-tagged ZIKV nonstructural proteins in G-I. For A-D and F-I, 24 h post-transfection, 
cells were lysed and proteins were separated by SDS-PAGE followed by Western blotting for 
the indicated proteins. In E, ImageJ was used to quantify band intensities for Western blots of 
each of the DENV non-structural proteins in EMC6 knockout cells compared to wild-type. Each 
dot represents a biological replicate, with independent transfections and Western blots. Bars 
represent means±SD. Mann-Whitney U was performed for statistical significance, with *, p<0.05 
and **, p<0.005 as compared to NS1. In J, Huh 7.5.1 cells stably harboring a DENV replicon 
were lysed and subjected to immunoprecipitation using an anti-EMC4 antibody or an isotype 
control. Immunoprecipitates were analyzed by immunoblotting with the indicated antibodies. In 
K, 293 cells transiently transfected to express either GFP-S or ZIKV NS4B-S were lysed 24 h 
later for affinity purification by S-protein conjugated beads and immunoblotting with the indicated 
antibodies. L, stable DENV replicon Huh 7.5.1 cells were transduced to express EMC4-FLAG. 
Immunostaining was performed for the indicated antigens with DAPI nuclear counterstaining, 
followed by confocal microscopy. 
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Figure 3.5. The EMC localizes to the DENV replication organelle. In A and B, Huh-7.5.1 
cells were stably transfected with a DENV replicon, then immunostaining was performed against 
the indicated antigens with DAPI nuclear counterstaining, followed by confocal microscopy. In C, 
quantitation of co-localization between EMC4-FLAG and NS4B or Calnexin and NS4B in 
replicon cells. Each point represents the Pearson’s correlation coefficient for a single cell, with 
the mean±SD.  
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Figure 3.6. EMC1 knockdown results in loss of other EMC subunits. HEK293 cells were 
transfected with a siRNA against EMC1 or scrambled control (scr) for 48 h. Cells were then 
lysed and subjected to SDS-PAGE and Western blotting for the indicated proteins. 
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Figure 3.7. Identification of DENV NS4B domains that confer EMC dependence.  In A, a 
diagram depicting the putative transmembrane domains in 2k-NS4B (gray bars) as listed in 
UniprotKB (accession P29990) with relative hydrophobicity scores, which are the average of the 
“transmembrane tendency scale” values described in (154) for the 20 amino acids in the helix. 
Values >0.8 indicate “high TM tendency” and values <0.3 indicate “low TM tendency”. The 
numbers within the transmembrane domains indicate amino acid numbers marking the terminal 
amino acids of each domain. In B, TMHMM (155) was used to predict membrane topology, and 
the resulting probabilities for each residue were plotted where greater values reflect greater 
transmembrane probability. Amino acid positions at the bottom indicate the terminal amino acids 
with scores above 0.3 for each predicted transmembrane domain. In C, 293T cells stably 
expressing Cas9 and sgRNA targeting EMC6 were co-transfected to express the indicated C-
terminally GFP-tagged NS4B mutants and NS1-FLAG as a transfection control. 2k-96 indicates 
a C-terminal truncation at amino acid 97. 2k-58 indicates a C-terminal truncation at amino acid 
59. Δ32-96 indicates a deletion from 32 to 96. 24 h post-transfection, cells were lysed and 
proteins were resolved by SDS-PAGE followed by Western blotting for the indicated proteins. In 
D, band intensity for NS4B Δ32-96 in EMC6 knockout cells compared to wild-type cells, where 
each dot represents an individual biological replicate from independent transfections and 
Western blots. 
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Figure 3.8. Model of hydrophobicity mutants of NS4B. The two NS4B marginally 
hydrophobic domains pTM1 and pTM2 are speculated to be membrane associated, with red 
representing hydrophobic residues, and blue representing charged and polar hydrophilic 
residues. Mutagenesis of the hydrophobic residues to lysine causes a change in topology, and 
withdrawal of pTM1 and pTM2 from the membrane. Mutation of the charged and polar residues 
to leucine results in the insertion of the domains into the membrane, as the domains now 
resemble canonical transmembrane domains. 
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Figure 3.9. NS4B EMC dependence is driven by marginal hydrophobicity. Wild-type or 
EMC6 knockout 293T cells were transfected to express various NS4B mutants. TM1-Leu 
indicates R33L, P34L, S36L, T39L, T35L, T36L, T39L mutations. In A, TM1-Lys indicates L32K, 
A35K, A37K, L40K, A42K, V43K, A44K, F47K mutations. In B, TM2-Lys indicates L84K, I89K, 
V91K, L93K, L94K mutations. TM2-Leu indicates TM2: K80L, P83L, S85L, K86L, D88L, P92L 
mutations. In C, bands were quantified by ImageJ and represented as a ratio of EMC6 knockout 
/ wild-type cells. Each point represents a biological replicate with bars representing the 
means±SD. Triangles represent quantification from blots after PNGase treatment. Circles 
represent total quantification from blots prior to PNGase. 
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Figure 3.10. NS4B removal in EMC depleted cells is mediated by ERAD. In A, wild-type or 
EMC6 knockout Huh 7.5.1 cells were transduced to express DENV NS4B-HA, then treated with 
10 µM MG132 for 6 h prior to lysis. In B, EMC6 knockout Huh 7.5.1 cells were stably transduced 
to express HA tagged DENV NS4B, ZIKV NS4B, or vector, then treated with 10 µM MG132 for 6 
h followed by lysis and immunoprecipitation with anti-HA antibody. In C and D, 293 cells were 
transfected with a siRNA against EMC1 to deplete the EMC. 48 h later, cells co-transfected to 
express the indicated p97 constructs or empty vector control with epitope tagged DENV or ZIKV 
NS4B. 24 h later, cells were lysed and immunoprecipitated for tagged NS4B. In A-D, proteins 
were separated by SDS-PAGE and visualized by Western blotting for the indicated proteins. 
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Figure 3.11. Alanine scanning of EMC6. Huh 7.5.1 cells were transduced to express a Cas9 
and sgRNA targeting EMC6 or non-targeting control (NT). Cells were then stably transduced 
again with a lentivirus encoding sgRNA resistant EMC6 harboring alanine mutations at 5 
consecutive residues. Numbers 2-22 indicate the position of the 5 amino acid (aa) mutation to 
EMC6, i.e. 1: aa 1-5, 2: aa 6-10, 3: aa 11-15, etc. KO indicates EMC6 knockout cells transduced 
with empty vector. WT indicates EMC6 knockout cells transduced with an sgRNA-resistant wild-
type EMC6. In A, cells were infected with luc-DENV for 2 days, then luciferase activity was 
measured. Each dot represents an independent biological replicate with bars representing the 
mean±SD. In B and C, representative Western blots show the level of expression of each HA-
tagged EMC6 mutant as well as EMC2 and EMC4, which are surrogate measures for rest of the 
EMC. 
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Figure 3.12. The N-terminal 20 amino acids of EMC6 are not required for complex 
assembly or infection. For A and B, Huh 7.5.1 cells were transduced to express a Cas9 and 
sgRNA targeting EMC6 or non-targeting control (NT). Cells were then stably transduced again 
with a lentivirus encoding sgRNA resistant EMC6 harboring truncations to either the C or N 
terminus. In A, C10 indicates 10 amino acid deletion at the C-terminus. In B, N20 represents a 
20 amino acid deletion at the N-terminus, etc. Cells were infected with luc-DENV for 2 days, 
then luciferase activity was measured. Each dot represents an independent biological replicate 
with bars representing the means±SD. Representative Western blots show the level of 
expression of each GFP-tagged EMC6 mutant as well as EMC2 and EMC4, surrogate 
measures for rest of the EMC. WT indicates wild-type EMC6. For N-terminal truncation mutants, 
EMC6 was C-terminally GFP tagged while C-terminal truncation mutants were N-terminally GFP 
tagged. 
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Table 3.1. List of guide RNAs for generating EMC knockout cells. Oligos were annealed 
and cloned into pLENTICRISPRv2. Constructs were co-transfected into 293Ts to generate VSV-
G pseudotyped lentiviruses for stable transduction of target cells. 
 
  
Sequence Comments 
CACCG AGGCCGAATCATGCGTTCCT F sgRNA targeting EMC1 
AAAC AGGAACGCATGATTCGGCCT C R sgRNA targeting EMC1 
CACCG ACGCATGATTCGGCCTCCAT F sgRNA targeting EMC1 
AAAC ATGGAGGCCGAATCATGCGT C R sgRNA targeting EMC1 
CACCG ATACTCATTCAGCTCCCGAA F sgRNA targeting EMC2 
AAAC TTCGGGAGCTGAATGAGTAT C R sgRNA targeting EMC2 
CACCG TAATGAATATGCTTCTAAGC F sgRNA targeting EMC2 
AAAC GCTTAGAAGCATATTCATTA C R sgRNA targeting EMC2 
CACCG TGCTTGTCCAAGTAACCGAC F sgRNA targeting EMC4 
AAAC GTCGGTTACTTGGACAAGCA C R sgRNA targeting EMC4 
CACCG CAATGGCCCACTTGAAGCGC F sgRNA targeting EMC4 
AAAC GCGCTTCAAGTGGGCCATTG C R sgRNA targeting EMC4 
CACCG AATATGAACTATACCGTAAC F sgRNA targeting EMC5 
AAAC GTTACGGTATAGTTCATATT C R sgRNA targeting EMC5 
CACCG GCATCATGGCGCCGTCGCTG F sgRNA targeting EMC5 
AAAC CAGCGACGGCGCCATGATGC C R sgRNA targeting EMC5 
CACCG ACGGCCGCCTCGCTGATGAA F sgRNA targeting EMC6 
AAAC TTCATCAGCGAGGCGGCCGT C R sgRNA targeting EMC6 
CACCG GACCTCGGTGTCAGCGCTGT F sgRNA targeting EMC6 
AAAC ACAGCGCTGACACCGAGGTC C R sgRNA targeting EMC6 
CACCG CCGGCAATAATCCAGGACGG F sgRNA targeting EMC6 
AAAC CCGTCCTGGATTATTGCCGG C R sgRNA targeting EMC6 
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CHAPTER IV 
Dominant-negative inhibition of flavivirus infection by heterologous expression 
of engineered non-structural protein 1. 
 The experiments to demonstrate inhibition of ZIKV and YFV infection by 
expression of various NS1 mutants were performed by Stephanie Azzopardi and 
Margaret R. MacDonald. Natalie McMyn assisted in the cloning of various NS1 
constructs. 
 
Introduction 
 Upon seeing the hits from the initial CRISPR-Cas9 screen, and prior to any 
characterization of the hits, my initial hypothesis was that loss of STT3A or STT3B 
would affect the glycosylation of NS1 and potentially its folding or stability, which in turn 
would prevent DENV replication. I had transduced WT and STT3A or STT3B knockout 
cells to express NS1, but found that I could not detect any differences in NS1, even 
using metabolic labeling to visualize nascent NS1 (Figure 2.6B). As a result, that 
hypothesis was quashed. As I had been in the process of validating hits from the screen 
by infecting knockout cells with a luciferase reporter DENV, I also decided to infect cells 
transduced with various NS1 constructs. To my surprise, I found that DENV replication 
was severely inhibited in cells expressing DENV NS1 harboring an N207A mutation. I 
decided to explore this phenomenon further, and the following are results that stem from 
the those observations. 
 
Hypoglycosylated NS1 blocks flavivirus replication in a dominant-negative 
fashion 
We stably transduced Huh 7.5.1 cells to express wild-type DENV-2 or ZIKV NS1, 
N130A NS1, N207A NS1, or the double mutant N130A N207A NS1, then subsequently 
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infected them with a luciferase DENV-2 reporter virus (luc-DENV) at an MOI = 0.1. Cells 
expressing wild-type DENV-2 NS1 (D-WT) supported elevated levels of infection 
compared to the parental cell line (Figure 4.1A). However, expression of DENV-2 NS1-
N207A (D-N207A) or the double mutant N130A N207A (D-ΔGlyco) dramatically reduced 
levels of infection by 2 logs as compared to the parental cell line (Figure 4.1A). 
Expression of DENV-2 NS1-N130A (D-N130A), on the other hand, had no effect on the 
level of DENV-2 infection, demonstrating that the inhibition of DENV-2 infection by 
hypoglycosylated D-N207A or D-ΔGlyco NS1 is not simply a nonspecific effect of NS1 
hypoglycosylation.  
Similarly, expression of ZIKV-NS1 wild-type (Z-WT) did not affect levels of 
DENV-2 infection compared to a vector control (Figure 4.1B). In contrast to DENV-2, 
ZIKV NS1-N207A (Z-N207A) did not affect DENV infection, while ZIKV NS1-N130A (Z-
N130A) or ZIKV NS1-ΔGlyco (Z-ΔGlyco ) reduced DENV infection by approximately 20-
fold (Figure 4.1B). 
Glycosylation of NS1 is dependent upon its insertion into the endoplasmic 
reticulum (ER) lumen via an N-terminal signal sequence encoded by the C-terminal 22 
amino acids of the DENV envelope protein (27). Therefore, we asked whether 
localization of NS1 in the ER lumen is necessary to block replication by expressing a 
mutant of DENV NS1 lacking this signal sequence, dubbed ΔSig. We find that ΔSig NS1 
remains unglycosylated and migrates at the same size as ΔGlyco NS1 by SDS-PAGE 
and Western blotting lysates obtained from the intracellular compartment of transduced 
cells (Figure 4.1A). After infection with luc-DENV, we found that cells expressing ΔSig 
NS1 supported infection to the same level as control cells. Although the expression level 
of ΔSig NS1 was lower than that of D-N207A or D-ΔGlyco, this data suggests that 
hypoglycosylated NS1 can only block DENV propagation if it resides within the ER 
lumen. 
 
DENV is blocked at the level of replication in NS1-N207A expressing cells 
We next sought to determine the step at which DENV infection was impaired in 
D-N207A and D-ΔGlyco expressing cells. We transfected 293T cells stably expressing 
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D-N207A or D-WT with a luciferase reporter replicon, which encodes a monocistronic N-
terminal luciferase tagged to a DENV subgenomic replicon containing the 7 non-
structural proteins required for DENV replication (24, 146). DENV replication was 
significantly impaired in D-N207A expressing cells compared to D-WT, with 
approximately 1 log reduction in luciferase activity (Figure 4.2A). This subgenomic 
replicon also encodes a puromycin gene for stable selection of cells supporting 
replication of the DENV replicon, so we further performed colony formation assays to 
determine whether we could recover mutations that allow DENV to replicate in cells 
expressing D-N207A (Figure 4.2B). Similar to the transient replicon assay, we found a 
dramatic decrease in the number of puromycin-resistant colonies formed on cells 
expressing D-N207A compared to D-WT (Figure 4.2B). Additionally, we transduced 
stable DENV replicon cells with a lentivirus encoding either D-WT or D-N207A and 
found that 2 weeks post-selection for the replicon and lentivirus, we were able to 
generate colonies in the D-WT condition, but not with D-N207A, suggesting that the 
addition of D-N207A can functionally cure cells of a DENV replicon (Figure 4.2C). 
In an attempt to identify mutations conferring resistance to D-N207A, we isolated 
double selected stable D-N207A DENV replicon colonies by ring selection. Western blot 
analysis showed that of twelve colonies, only three expressed detectable levels of D-
N207A; replicon RNA from these cells was cloned and sequenced. In one replicon, we 
found an I167L mutation in NS1, and another had a K60E mutation in NS2B. In the third 
colony, the replicon was determined to be wild-type. Using reverse genetics, we 
introduced NS1-I167L or NS2B-K60E mutations into the subgenomic replicon and 
repeated the colony formation assay to determine their level of resistance to D-N207A. 
After transfection of these mutant replicons into NS1 expressing cells, we found that 
these mutations did not significantly affect colony formation in D-N207A cells, indicating 
that these mutations did not grant substantial resistance to the dominant-negative 
effects of D-N207A (Figure 4.2D). 
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Inhibition by DENV N207A is MOI dependent 
We hypothesized that D-N207A and Z-N130A inhibit replication in a trans-
dominant manner through heterodimerization with wild-type NS1 molecules expressed 
from the viral RNA, which in turn blocks replication. In this model, we would predict that 
the dominant negative inhibition is dependent on the ratio between NS1-N207A and 
virally encoded NS1-WT. Therefore, we infected cells with increasing MOI to determine 
whether we could overcome the effect of NS1-N207A. After infection, we measured 
NS4B viral protein expression by Western blot 2 days post-infection as a surrogate for 
virus propagation. Additionally, we probed for total NS1, which includes both 
exogenously expressed and virally encoded NS1. 
In WT-NS1 expressing cells, we found that NS4B protein levels were similar 
across cells infected at MOI 0.1 to 10, suggesting that these cells are already maximally 
infected at 2 days post infection (Figure 4.3A). However, in D-N207A expressing cells, 
NS4B expression correlated strongly with MOI, with increasing levels of NS4B at higher 
MOI (Figure 4.3A). At MOI 0.1, NS4B was undetectable, while at MOI 10, NS4B levels 
were similar to D-WT expressing cells infected at MOI 0.1. Similar data were found 
when we measured total NS1 expression (Figure 4.3A). We also show that the 
exogenously expressed NS1 is present at a level far below that of infection (Figure 
4.3A). This data shows that the block in DENV replication by NS1-N207A is dependent 
on the MOI, indicating that the stoichiometry between virally encoded NS1-WT and D-
N207A is critical to the dominant-negative inhibition of replication. 
 
Hypoglycosylated NS1 can heterodimerize with wild-type NS1 
As our model predicts that D-N207A forms heterodimers with virally encoded WT 
NS1, we proceeded to test the ability of the NS1 mutants to form heterodimers with WT 
NS1 by co-immunoprecipitation (co-IP). We co-transfected cells to express FLAG-
tagged D-WT and HA-tagged D-N207A, or vice-versa, performed co-IP with anti-HA 
antibody, and then performed Western blotting to detect the presence of FLAG. We 
found that D-WT was able to interact with D-N207A by IP of either D-WT or D-N207A 
(Figure 4.3B), confirming that the two NS1s are able to heterodimerize. The degree of 
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dimerization was similar between two D-WT molecules as between D-WT and D-N207A, 
suggesting that the N207 glycosylation does not play a major role in the dimerization of 
NS1 (Figure 4.3B). NS1 exists almost exclusively as a dimer within cells, suggesting 
that these interactions are not due to homodimers forming hexamers (38, 124). 
Additionally, the level of expression by transient transfection or stable transduction is far 
below the level of NS1 expression during viral replication (Figure 4.3A), demonstrating 
that even under relatively low levels of expression, NS1 heterodimers are prevalent. 
Because Z-N130A was also capable of inhibiting DENV infection, we performed 
co-IPs using Z-N130A and DENV NS1. Similarly, we found that Z-N130A could interact 
with D-WT, though to a significantly lesser degree than two DENV NS1 molecules 
(Figure 4.3C). We also tested whether a hypoglycosylated DENV NS1 could dimerize 
with ZIKV NS1, and found that the regardless of glycosylation status, ZIKV NS1 and 
DENV NS1 could still interact (Figure 4.3C), again suggesting that the glycosylation 
status of DENV or ZIKV NS1 does not affect hetero- or homo-dimerization within cells. 
 
Engineered NS1 chimeras inhibit DENV infection 
 We next sought to determine whether we could isolate specific motifs in ZIKV 
and DENV NS1 that guide Z-N130A and D-N207A to block DENV replication, but not Z-
N207A or D-N130A. The exogenously expressed sequences for ZIKV NS1 and DENV-2 
NS1 share 54% identity, with 162 of 352 amino acids being different. The N-terminal 
129 amino acids share only 43% identity, with 73 residues differing between the two. 
We hypothesized that specific residues at the N-terminus of NS1 may influence whether 
the N130A or N207A NS1 proteins are able to inhibit DENV infection. Therefore, we 
used a classic approach to study differences in homologous proteins through generating 
chimeric NS1 fusions. We constructed plasmids to express fusion proteins where we 
swapped the first 129 amino acids from ZIKV NS1 with DENV NS1 (D(1-129)-Z(130-
352), now referred to as D-Z) and vice-versa where the first 129 amino acids from 
DENV NS1 were mutated to ZIKV (Z(1-129)-D(130-352), now referred to as Z-D) 
(Figure 4.4A).  
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Western blotting indicated that the Z-D chimeras had an apparent mobility pattern 
similar to DENV NS1, suggesting that they also were glycosylated as engineered 
(Figure 4.4C). To our surprise, stably transduced cells expressing chimeric Z-D NS1 
dramatically inhibited luc-DENV infection in a glycosylation independent manner, with 
fully glycosylated Z-D NS1 blocking luc-DENV-2 infection by over 200 fold (Figure 4B). 
D-Z NS1 also inhibited luc-DENV infection but to a lesser degree, with D-Z WT inhibiting 
luc-DENV only 5-fold, and D-Z N130A blocking infection by 10-fold. Interestingly, D-Z 
N207A exhibited the greatest level of inhibition among the D-Z chimeras, with luc-DENV 
infection reduced approximately 30-fold (Figure 4.4B). We also demonstrated that both 
of these chimeric NS1s were able to form heterodimers with DENV NS1-WT, further 
providing evidence that heterodimerization may be important for the inhibition of viral 
replication (Figure 4.4D).  
 
N207A-NS1 exhibits aberrant localization upon DENV infection 
We then performed immunofluorescence microscopy to compare the localization 
of epitope tagged D-N207A and D-WT after DENV infection. We visualized the 
exogenously expressed NS1 with antibodies against FLAG or HA and also marked 
infected cells with an antibody against DENV NS4B. In uninfected cells, D-WT, D-
N130A, and D-N207A were distributed in a reticular pattern consistent with their known 
localization to the ER lumen. Two days post-infection, both D-NS1 and D-N130A 
localized to distinct foci in infected cells (Figure 4.5A), similar to previous reports where 
NS1 was localized to replication complexes (46). 
By contrast, the morphology and localization of D-N207A were dramatically 
different from D-WT after DENV infection. In many infected cells, D-N207A appeared in 
brightly staining accumulations that often appeared filamentous (Figure 4.5A). 
Importantly, we also noticed that cells not yet expressing visually apparent levels of 
NS4B also contained these filamentous N207A-positive structures (Figure 4.5A). These 
cells were frequently found in the immediate vicinity of NS4B-positive cells, suggesting 
that these cells were undergoing the early stages of infection. By contrast, in cells 
expressing high levels of NS4B, D-N207A often appeared to distribute in a punctate 
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pattern more similar to D-WT. The apparent inverse association between the 
appearance of D-N207A accumulations and the level of NS4B expression is consistent 
with our model’s prediction that the strength D-N207A dominant negative inhibition is a 
function of the ratio of mutant to WT NS1 levels.  
Furthermore, we found that Z-N130A exhibits a filamentous phenotype 
comparable to D-N207A upon DENV infection, suggesting that the mechanism of 
inhibition by Z-N130A and D-N207A are similar (Figure 4.5B). 
A fraction of NS1 is secreted through the Golgi apparatus as hexamers, therefore 
we performed co-staining of infected cells with the vesicle marker β-COP, and found 
that neither D-WT nor D-N207A colocalized with β-COP vesicles after infection, 
demonstrating that the N207A filaments were not in the Golgi apparatus (Figure 4.5C). 
NS1 and other viral non-structural proteins form replication complexes at the ER 
membrane, which co-localize with calnexin (49). Consistent with these findings, we 
found that exogenously expressed D-WT accumulated at calnexin positive sites after 
DENV infection (Figure 4.5D). However, D-N207A filaments did not co-localize with 
calnexin after infection, suggesting that they reside in a distinct cellular compartment 
(Figure 4.5D). These filaments often appeared to be excluded from calnexin-positive 
regions of the ER.  
 
Dimerization as a determinant of the dominant-negative effect 
We next wanted to determine whether the ability to form heterodimers was 
necessary for the dominant-negative inhibition on flavivirus replication by D-N207A. We 
attempted to generate mutant NS1 that would not dimerize with virally encoded wild-
type NS1. We generated a mutant NS1 with 4 substitutions (K182D N191K K227D 
N234K) at the dimer interface targeting charged and non-conserved residues in an 
attempt to hinder the formation of NS1 heterodimers (D-WT-4x and D-N207A-4x) 
(Figure 4.6A). We chose non-conserved residues as we hypothesized that mutations at 
conserved residues could affect NS1 function and disrupt the dominant-negative 
phenotype in a mechanism independent of dimerization. However, these four mutations 
were insufficient to block heterodimerization with wild-type NS1, as detected by co-IP 
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(Figure 4.6B). Upon infection with luc-DENV, we found that these mutants no longer 
displayed the same dominant-negative effect as D-N207A (Figure 4.6C). D-WT-4x 
expressing cells and D-N207A-4x cells supported similar levels of DENV infection, 
which were slightly reduced compared to parental control (Figure 4.6C).  
 
Engineered NS1 mutants inhibit infection by multiple flaviviruses 
 We next tested whether these NS1 mutants also exhibit dominant negative 
activity against other flaviviruses. We tested whether ZIKV or YFV could propagate in 
cells stably expressing DENV or ZIKV NS1. Using flow cytometry to measure the 
percentage of infected cells, we found that ZIKV was unaffected by expression of DENV 
NS1 or glycosylation mutants of DENV NS1 (Figure 4.8A). Like DENV-2, ZIKV was also 
inhibited by Z-N130A and not by Z-N207A (Figure 4.8A). Surprisingly, we also found 
that YFV was unable to replicate in cells expressing DENV or ZIKV NS1 regardless of 
glycosylation status (Figure 4.8B). 
 
Discussion 
Despite considerable effort over the past two decades and the recent elucidation 
of its structure, the molecular mechanisms by which flavivirus NS1 supports both 
genome replication and virion assembly remain unclear. Part of this mystery includes 
the role of flavivirus NS1 glycosylation. The strict conservation of NS1 glycosylation at 
N130 and N207 in all flaviviruses suggests that these sequons play important roles 
during infection. Furthermore, others have shown that mutant viruses lacking specific 
NS1 glycosylation sequons are attenuated in vivo and in vitro (31-34, 36).  Our data 
show that expression of mutant NS1 lacking specific glycosylation sequons from both 
ZIKV and DENV can act in a dominant-negative fashion blocking flavivirus replication.  
Importantly, we showed that Z-N130A is a potent inhibitor of multiple flaviviruses 
including DENV, YFV, and ZIKV, while D-N207A blocks only DENV-2 and other DENV 
serotypes. This cross-virus inhibition suggests that the exogenously expressed NS1 
somehow poisons replication, most likely through heterodimerization with virally 
encoded NS1. We provided evidence that ZIKV NS1 and DENV NS1 can form 
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heterodimers, albeit with lower affinity than DENV NS1 homodimers. This difference in 
affinity also correlates with the degree of inhibition, as D-N207A reduces DENV-2 
propagation by about 2-4 fold more than Z-N130A. In addition, inhibition of infection is 
MOI dependent, suggesting that the ratio of inhibitory NS1 to virally encoded non-
structural proteins is a critical determinant of replication inhibition. We cannot exclude 
the possibility that hypoglycosylated NS1 homodimers can also inhibit infection through 
a mechanism independent of heterodimerization with virally encoded NS1. 
We speculate that inhibitory NS1 molecules block replication in a mechanism that 
is dependent on interactions with other flavivirus non-structural proteins or host 
dependency factors. In support of this hypothesis, NS1 mutants display varying 
specificities in their ability to block flavivirus infection. For example, D-N207A does not 
block ZIKV infection, but is able to inhibit DENV infection. This suggests that 
hypoglycosylated NS1 is not nonspecifically detrimental to flavivirus infection, but that 
inhibitory NS1 heterodimers might block the assembly of the viral replicase or 
recruitment of a host dependency factor to the viral replication organelle. NS1 has been 
shown to interact with NS4A and NS4B (41, 47), which may be viral determinants that 
guide whether NS1 mutants can block infection. We sought but were unable to isolate 
viral mutations that conferred resistance to inhibitory NS1 proteins. 
We also attempted to map NS1 determinants that drive N130A or N207A to 
exhibit an inhibitory phenotype by generating chimeric ZIKV and DENV NS1 fusion 
proteins. Simply swapping the first 130 amino acids on fully glycosylated DENV NS1 to 
ZIKV yielded a potent inhibitor of DENV infection. Likewise, all tested DENV and ZIKV 
NS1 molecules, both glycosylated and hypoglycosylated, blocked YFV infection. These 
data suggest that NS1 N-glycosylation and specific amino acid residues are both 
required for the association of NS1 with non-structural proteins or cellular factors to 
establish a functional replication complex, and that these interactions can be targets of 
dominant negative inhibition by NS1 mutants. 
We made several attempts to produce NS1 mutants that were unable to form 
heterodimers to ask whether heterodimerization was necessary for dominant-negative 
inhibition. Unfortunately, using our co-immunoprecipitation assay, each of these mutants 
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was still capable of forming heterodimers with NS1-WT. However, D-WT-4x did not 
enhance DENV infection, and D-N130A-4x but could not efficiently block DENV infection, 
suggesting that either the NS1-4x mutants are able to heterodimerize with NS1-WT but 
fail to be recruited to the DENV replication complex, or that these NS1-4x mutants fail to 
form heterodimers with viral NS1 in the context of viral infection.   
One hint at the potential mechanism of inhibition by the dominant-negative NS1 
mutants is the altered distribution of inhibitory NS1 in infected cells, but not in uninfected 
cells. Using immunofluorescence, we were able to detect unusual NS1-positive 
structures in the early stages of infection of D-N207A and Z-N130A expressing cells, 
even prior to detectable accumulation of virally encoded proteins. These filamentous 
structures are reminiscent of those formed in cells expressing the CAP domain of the 
Bromovirus (BMV) 1a protein, which also functions as a dominant negative inhibitor of 
BMV replication in a mechanism dependent on multimerization (156). As aberrant NS1 
distribution is observed only in the context of viral infection (e.g. not by cotransfection of 
D-N207A with D-WT or other DENV non-structural proteins), our data suggest that 
mutant NS1 redistribution is driven by heterodimerization with virally encoded NS1 in the 
context of polyprotein expression. 
We also explored whether rationally designed NS1 chimeras could block 
flavivirus replication. The Z-D NS1 chimera was a potent inhibitor of DENV, despite 
being fully glycosylated at N130 and N207. Because ZIKV NS1-WT and DENV NS1-WT 
did not affect DENV infection, this suggests that the Z-D chimera is functionally distinct 
from its parental NS1s. The Z-D chimeras displayed possible glycosylation dependence, 
with N207A or N130A blocking infection to greater degrees than its fully glycosylated 
counterpart. As wild-type Z-D reduced the level of infection to our assay’s limit of 
detection, future work will determine whether glycosylation of this chimera affects its 
dominant-negative activity.  
The D-Z NS1 chimeras more clearly exhibited a modest but significant degree of 
glycosylation dependence, with both N130A and N207A inhibiting luc-DENV infection to 
greater degrees than wild-type. Because D-N207A and Z-N130A both blocked DENV 
infection, but not D-N130A or Z-N207A, these data suggest that the D-Z NS1 chimeras 
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may retain properties of both DENV and ZIKV NS1s in their ability to inhibit flavivirus 
infection. 
 We are currently exploring whether exogenous expression of engineered NS1 
molecules in insect cells can similarly block flavivirus infection. Additionally, we predict 
that this phenomenon of dominant negative NS1 inhibition may be generalizable to 
other flaviviruses such as West Nile virus and that engineered NS1 mutants may be 
useful in controlling flavivirus dissemination. While the mechanism of this dominant-
negative inhibition is unclear, this work provides tools to better understand the function 
of NS1 during viral replication. 
 
Materials and Methods 
Plasmids and lentiviral transduction 
 The DENV serotype 2 strain 16681 cDNA clone pD2/IC-30P-NBX was used as a 
template for generation of all DENV mutants (135). The ZIKV Paraiba_01/2015 strain 
cDNA clone ZIKV-ICD was used as a template for generation of the ZIKV mutants 
(153); the intron inserted into NS1 to enhance genetic stability of the clone was removed 
by overlap extension PCR prior to generation of mutants and subcloning of ZIKV NS1 
into a lentiviral expression vector. 
For all mutations, overlap extension PCR was performed to generate mutants 
that were subsequently cloned into the pSMPUW lentiviral expression vector (Cell 
Biolabs, San Diego, CA). Detailed descriptions of these constructs are available upon 
request. Lentiviral expression constructs were used to generate VSV-G-pseudotyped 
lentiviruses and for stable transduction of target cells as previously described (24). 
Expression after lentiviral transduction or transient transfection was confirmed by 
Western blotting. 
The DENV 4x NS1 mutants harbor the following mutations: K182D N191K 
K227D N234K. These residues were chosen based on the crystal structure of the DENV 
NS1 dimer (PDB: 4O6B).  
 
Viruses and replicons 
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The infectious DENV serotype 2 strain 16681 cDNA clone pD2/IC-30P-NBX was 
used to generate full-length viral RNA, and the luciferase reporter virus and replicon as 
previously described (146). Luc-DENV was titered by fluorescence focus assay using 
the 4G2 pan-flavivirus anti-envelope antibody to detect infected cells. To generate 
replicon RNA, linearized cDNA was in vitro transcribed, and capped with the 
m7G(5’)ppp(5’)A cap analog (New England Biolabs) using T7 Megascript (Thermo 
Fisher Scientific, Waltham, MA). Recombinant infectious virus for YFV-Venus was 
generated as previously described (139). ZIKV 2015 Puerto Rican PRVABC59 strain 
(144), was obtained from the CDC and passaged twice in Huh-7.5 cells prior to use in 
these experiments. 
 
Antibodies 
Western blots were performed using antibodies against HA (C29F4) from Cell Signaling 
Technology (Danvers, MA), and FLAG (F1804) from Sigma Aldrich. The anti-NS1 
monoclonal antibody 1F11 was a gift from Dr. Malasit at the National Center for Genetic 
Engineering and Biotechnology in Thailand. For immunofluorescence assays, 
immunostaining was performed with anti-DENV-NS4B (Genetex GTX103349) (1:1000), 
anti-HA (Cell Signaling Technologies C29F4) (1:200), anti-FLAG (Sigma Aldrich F1804) 
(1:500), anti-NS1 (1:50), anti-calnexin (Santa Cruz Biotechnologies sc-23954) (1:100), 
or anti-beta-COP (Sigma Aldrich G2279) (1:200).  
 
Flow Cytometry 
For analysis of ZIKV and YFV replication, cells were infected at low MOI for 4 days, 
then fixed with 4% paraformaldehyde prior to analysis by flow cytometry on a BD LSR II 
flow cytometer. For ZIKV, cells were stained with 4G2 antibody to detect infected cells. 
For YFV-Venus, cells were directly observed for Venus expression. Data was analyzed 
using FloJo version 10.2, with the positive gate set such that <1% of uninfected cells 
resided in the positive gate.  
 
Transient replicon and colony formation assay 
 87 
Cells were transfected with in vitro transcribed and capped replicon RNA using 
TransIT-mRNA reagent (Mirus Bio, Madison, WI) in a 6-well plate. For the transient 
replicon assay, cells were trypsinized 4 h post-transfection, and 50% of the cells were 
lysed to measure luciferase activity as a surrogate for transfection efficiency 
normalization, while the remaining cells were re-seeded on a 6-well plate for future 
luciferase readings. Two or three days post-transfection, cells were lysed and luciferase 
activity was measured to determine levels of replication. 
For the colony formation assay, one day post-transfection of replicon RNA, cells 
were trypsinized, seeded on 60 mm dishes, and selected using puromycin (for the 
replicon), blasticidin (for exogenous NS1), or both drugs. One week later, media was 
removed and cells were washed twice with PBS before crystal violet staining, or 
colonies were selected using a cloning cylinder for expansion and sequencing. 
 
Co-Immunoprecipitation and Western blotting 
For co-IP and Western blotting, cells were lysed in a buffer containing 20mM Tris 
pH 7.5, 100mM NaCl, 1% Triton X-100, 10% glycerol, and 1mM EDTA with the addition 
of Halt protease inhibitor. Co-immunoprecipitation and Western blotting was performed 
as previously described (24).  
 
Immunofluorescence 
Cells were plated on poly-D-lysine coated coverslips and fixed in ice cold 100% 
methanol for 1 h at -20˚C. Coverslips were then blocked in 2% BSA + 0.1% Triton X-100 
in 1x PBS for 1 h at room temperature. Primary antibodies were diluted in blocking 
buffer and immunostaining was performed. Cells were then washed, probed with 
secondary fluorophore conjugated antibodies, and mounted as previously described 
(146). 
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Figure 4.1. Heterologous expression of hypoglycosylated mutants of DENV or ZIKV NS1 
blocks DENV-2 propagation. In A, Huh 7.5.1 cells were stably transduced to express the 
indicated DENV NS1 constructs. ΔSig is an NS1 mutant that lacks the N-terminal signal 
sequence required for insertion of NS1 into the ER lumen and is therefore not glycosylated. 
Cells were infected with a luciferase reporter DENV at an approximate MOI of 0.1, and 
luciferase activity was measured 3 d post-infection. In B, Huh 7.5.1 cells were stably transduced 
to express ZIKV NS1 mutants as indicated. The same infection conditions were used as in A. 
Data are plotted as a percent of the relative luciferase units (RLU) in the parental cell line Huh 
7.5.1 where each dot represents a biological replicate. Bars indicate means ± standard 
deviations. **, p< 0.005, ***, p < 0.0005 by Mann-Whitney U test compared to Parental. Lower 
panel is a Western blot for NS1 and actin as a loading control.  
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Figure 4.2. NS1 mutants inhibit DENV at the level of replication. In A, Huh 7.5.1 cells stably 
transduced to express the indicated NS1 constructs were transfected with a luciferase DENV 
replicon, and luciferase activity was measured at 4 hr and 48 hr post-transfection (hpt). Data are 
plotted as a ratio of relative luciferase units (RLU) to RLU at 4 hpt to control for transfection 
efficiency. Bars indicate means ± standard deviation. *, p < 0.05 by Mann-Whitney U test 
compared to Parental. In B and D, 293T cells stably expressing DENV NS1-WT or DENV NS1-
N207A (blasticidin-resistant) were transfected with a DENV replicon expressing a puromycin 
selection marker. 24 hr post-transfection, cells were double selected with blasticidin and 
puromycin, and colonies were visualized by crystal violet staining 10 d post-selection. In C, Huh 
7.5.1 cells stably harboring a DENV replicon (puromycin-resistant) were transduced with a 
lentivirus encoding blasticidin and DENV NS1-WT or NS1-N207A. Cells were double selected 
24 hr post-transduction and colonies were visualized by crystal violet staining 10 d post-
selection. In D, cells were transfected with a DENV replicon harboring the indicated mutation.  
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Figure 4.3. ZIKV and DENV NS1 glycosylation mutants can heterodimerize with DENV 
NS1. In A, Huh 7.5.1 cells stably expressing the indicated DENV NS1 constructs were infected 
with DENV-2 at the indicated MOIs for 48 hr. Cells were lysed for SDS-PAGE and Western 
blotting for total NS1 and NS4B as measures of viral infection and to demonstrate the relative 
levels of exogenous NS1 expression (in uninfected cells) compared to virally encoded NS1. In B 
and C, 293T cells were co-transfected to express plasmids expressing the indicated NS1 
constructs. Co-immunoprecipitation of HA-NS1 was followed by SDS-PAGE and Western 
blotting for FLAG-NS1. In C, the interaction between ZIKV and DENV NS1 is relatively weak, 
requiring a longer exposure to visualize FLAG.  
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Figure 4.4. Engineered chimeric NS1 constructs inhibit DENV replication. In A, a 
schematic for the NS1 chimeras. The Z-D NS1 harbors ZIKV amino acids 1-129, and DENV 
amino acids 130-352. The D-Z NS1 harbors DENV amino acids 1-129, and ZIKV amino acids 
130-352. In B, Huh 7.5.1 cells stably expressing FLAG tagged chimeric NS1 constructs were 
infected with a luciferase reporter DENV and luciferase activity was measured 3 d post-infection. 
Data are plotted as a percent of the relative luciferase units (RLU) from the parental Huh 7.5.1 
cell line where each dot represents a biological replicate. Bars indicate means ± standard 
deviations. ***, p < 0.0005 by Mann-Whitney U test compared to Parental. In C, Western blots 
show the migration pattern of the chimeric NS1 constructs. In D, 293T cells were co-transfected 
to express the indicated NS1 constructs. Immunoprecipitation of HA-NS1 was followed by SDS-
PAGE and Western blotting for FLAG-NS1.   
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Figure 4.5. Mutant NS1 constructs form filamentous accumulations in DENV-infected 
cells. In A, C and D, Huh 7.5.1 cells stably expressing FLAG or HA tagged DENV NS1 WT, 
N130A, or N207A were either mock infected or infected with DENV-2 for 3 d at MOI = 1. In B, 
Huh 7.5.1 cells stably expressing FLAG tagged ZIKV NS1 WT or N130A were infected with 
DENV-2 for 3 d at MOI = 1. In A-D, cells were then fixed, permeabilized, and immunostained 
with antibodies against the indicated protein. Nuclei were visualized by DAPI counterstaining. In 
A, slides were visualized by epifluorescence microscopy. In B-D, slides were visualized by 
confocal microscopy. 
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Figure 4.6. Mutations to the NS1 dimer interface do not interfere with heterodimerization, 
but impair glycosylation-dependent inhibition of DENV replication. In A, the four mutated 
residues of the 4x NS1 mutants are depicted on the crystal structure of the DENV NS1 dimer 
where one NS1 monomer is colored in yellow and the other in orange. In B and C, the 4x 
indicates 4 mutations: K182D N191K K227D N234K. In B, 293T cells were co-transfected to 
express plasmids expressing the indicated NS1 constructs. Immunoprecipitation of DENV NS1-
HA was followed by SDS-PAGE and Western blotting for the indicated proteins. In C, Huh 7.5.1 
cells stably expressing the indicated mutants were infected with a luciferase reporter DENV for 3 
d when luciferase activity was measured, and plotted as a percentage of the Parental. Western 
blots below the graph show expression patterns for each of the mutants. *, p<0.05 by Mann-
Whitney U test compared to Parental.  
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Figure 4.7. Cross-flavivirus inhibition by expression of engineered NS1 constructs. In A, 
Huh 7.5.1 cells expressing the indicated NS1 constructs were infected with ZIKV for 2 d, then 
fixed and immunostained for E protein as a marker of infection. Flow cytometry was then used 
to quantify the percentage of infected cells. In B, the indicated cells were infected with a Venus 
expressing reporter YFV. Cells were fixed, and then flow cytometry was used to measure a 
percentage of cells expressing Venus. Data are plotted as a percentage of infected cells 
normalized to Parental Huh 7.5.1 control cells, with each dot representing an independent 
infection and bars representing the mean with standard deviations. *, p<0.05, **, p <0.005, ***, p 
< 0.0005 by Mann-Whitney U test compared to Parental. 
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CHAPTER V 
Concluding remarks and future directions 
 
The OST and EMC 
 We showed that both the OST and EMC are important cellular factors necessary 
for DENV replication. Furthermore, we provide evidence that NS4B is a likely target of 
both of these complexes. While the specific role of the OST in this process is unclear, 
we showed that the EMC is important for NS4B biogenesis and folding, and the EMC 
likely interacts with the two N-terminal marginally hydrophobic helices of NS4B and 
mediates their proper folding. We speculate that the reduced biogenesis of NS4B in 
EMC knockout cells is due to alterations in folding, leading to recognition and 
subsequent degradation by ERAD machinery. 
 While we have invested significant effort to probe the nature of NS4B’s 
dependence on the EMC, we have yet to clarify how NS4A is also EMC dependent. 
Similar to NS4B, NS4A contains a marginally hydrophobic domain at its N-terminus in 
the form of an amphipathic helix. Truncation and mutagenesis of NS4A will reveal 
whether the hydrophobicity of this domain is important for its association with the EMC.  
 To this point, we have not specifically ruled out impaired translation as a cause 
for reduced biosynthesis of NS4B. However, because EMC knockout does not result in 
changes to the expression of other DENV structural and non-structural proteins, overall 
translation is likely relatively unaffected. We also show that in the context of the full 
ZIKV polyprotein, the N-terminal E protein is unaffected by loss of the EMC, but NS4B 
expression is significantly reduced. However, it is still possible that translation of specific 
proteins is impaired in EMC knockout cells, and further experiments using metabolic 
labeling will shed light on this possibility. 
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 While the folding of NS4B is difficult to directly measure using readily available 
assays, the combined biochemical data suggest that NS4B folding is affected by loss of 
the EMC or OST. The glycosylation status of NS4B in OST and EMC knockout cells is 
altered, suggesting that either those complexes are directly responsible for NS4B 
glycosylation, or that the sequons normally accessible to the OST are inaccessible in 
the absence of the OST or EMC. For example, the glycosylation pattern of TM2-Lys 
NS4B mutant is drastically different between WT and EMC knockout cells, even in the 
presence of both STT3A and STT3B OSTs (Figure 3.9). This data would suggest that 
the sequons exhibit differential sequon accessibility to the ER lumen in the presence or 
absence of the EMC. This further implies an alteration in NS4B transmembrane helix 
insertion into the membrane, and a difference in folding. The accessibility of sequons is 
a useful measure of protein folding, however, the inability to directly probe which helices 
are membrane inserted limits the extent to which we can biochemically demonstrate that 
the EMC is a transmembrane protein chaperone. Hopefully, future in vitro assays will be 
able to more specifically interrogate the folding of NS4B in the presence and absence of 
the EMC or OST.  
 Many questions remain about the nature of the association between the OST and 
EMC in both cell biology and flavivirus infection. As both complexes have been shown 
to act co-translationally, perhaps the EMC is responsible for recruitment of substrates to 
the OST or vice versa.  Future experiments will also reveal the kinetics of OST and EMC 
substrate recognition, and uncover interesting aspects of transmembrane protein folding. 
 Alanine scanning and truncation mutagenesis of EMC6 revealed important 
domains for EMC stability and function. Similar experiments with other EMC subunits 
will be critical to identifying EMC residues important for its function. Additionally, a high-
resolution structure of the EMC would provide critical biochemical data, which can be 
used for targeted mutagenesis and inhibitor design. Further experiments characterizing 
how each EMC subunit contributes to EMC function will be critical to understanding how 
it engages marginally hydrophobic transmembrane substrates, but not proteins with 
canonical transmembrane helices. 
 
 97 
Dominant-negative inhibition by NS1 mutants 
 We showed that exogenous expression of a single NS1 mutant inhibits flavivirus 
infection. Future experiments can help identify the mechanism by which NS1 blocks 
replication, and grant important insight to the function of NS1 during replication. First, 
we speculate that heterodimerization of the NS1 mutant with wild-type viral NS1 is 
important for its inhibition. Expression of a homodimeric NS1 mutant could address this 
question, perhaps through expression of a tandem NS1 construct. Second, the evidence 
suggests that the interaction of NS1 with other non-structural proteins likely mediates its 
inhibition. It is possible that adaptive mutations to viral non-structural proteins could 
grant resistance to the dominant-negative inhibition by these NS1 mutants. While our 
attempts to generate resistant replicons were unsuccessful, future experiments 
passaging virus may provide some valuable insight. 
 The filamentous distribution of these NS1 mutants after infection indicates that 
the physical structure of the replication organelle may be affected early during infection. 
Ultrastructural analysis of infected cells by electron microscopy would provide 
meaningful data on the subcellular localization of these filaments. Another way to 
characterize these filaments is to use an NS1-APEX fusion protein to label and identify 
nearby proteins by mass-spectrometry, thus identifying the compartment where the 
filaments reside.  One major hurdle to these approaches is the heterogeneity of filament 
formation, which appears to be somewhat stochastic upon infection. 
 The translational application of these NS1 mutants has also been brought into 
question. The most feasible application of these mutants is through expression in 
mosquito vectors, which would theoretically grant the mosquito resistance to flavivirus 
infection, and prevent the transmission of the virus to people. Initial experiments will 
determine whether these NS1 mutants can prevent flavivirus replication in mosquito and 
insect cells. If these NS1 mutants can inhibit replication in mosquito cells, then the next 
obvious step would be to generate transgenic mosquitos expressing NS1 that is 
inherited via gene drive. By contrast, if these NS1 mutants inhibit replication in human 
cells but not insect cells, this data would provide strong evidence that NS1 mutants act 
as dominant-negative inhibitors via a human cellular host factor. 
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Conclusions 
 We demonstrated that pooled CRISPR-Cas9 screens are a highly reproducible, 
robust, and powerful tool for generating hypotheses. This technology can be rapidly 
applied to ask about genes that are important for various cellular processes, including 
viral infection. The identification of the EMC and MAGT1 as DENV host factors provides 
a strong fundamental basis for the design of inhibitors that can be used as antiviral 
therapeutics. Most importantly, the characterization of the EMC and its biochemistry are 
critical findings that contribute our understanding of cell biology. 
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